paclitaxel has been researched along with Sensitivity and Specificity in 205 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 23 (11.22) | 18.2507 |
| 2000's | 113 (55.12) | 29.6817 |
| 2010's | 64 (31.22) | 24.3611 |
| 2020's | 5 (2.44) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Awale, S; Esumi, H; Kadota, S; Li, F; Onozuka, H; Tezuka, Y | 1 |
| Chen, GY; Fong, WF; Globisch, C; Hu, YJ; Shen, XL; Tse, AK; Wiese, M; Yu, ZL; Zhu, GY | 1 |
| Biggerstaff, J; Kabalka, G; Le Puil, M; Miao, W; Townsend, D; Wall, J; Yao, ML; Zeng, W | 1 |
| Abbey, L; Abdelghany, TM; Abdellatif, MH; Abdelmohsen, UR; Abduljaleel Alzawar, NS; Abid, MF; Abu Kasim, AFB; Abu Saad, H; Adolpho, LF; Agostini, F; Agrizii, AP; Ahmed, S; Akce, M; Åkesson, D; Al-Awaadh, AM; Al-Mutar, DMK; Al-Odayni, AB; Al-Rajhi, AMH; Alaaeldin, R; Alam, M; Alam, MM; Alanazi, MA; Alattar, H; Alawlaqi, MM; Aldebis, HK; Algehainy, NA; Almeida, AA; Aloisi, F; Alrahlah, A; Alsenani, F; Alshabib, A; Altemani, FH; Althagafi, A; Amari, A; Andronesi, AG; Antonyuk, M; Arantes, TD; Araújo, R; Arrotti, S; Asakura, T; Asib, N; Atlaskin, AA; Aung, MS; Axiaq, A; Azekawa, S; Bacon, S; Bagalagel, A; Balbinot, GS; Barnet, LS; Baroyi, SAHM; Barreto, F; Barth, Y; Barysheva, AV; Bassa, E; Basu, R; Basu, S; Bates, C; Bautista, LS; Beitl, K; Beloti, MM; Benatti, G; Benavent-Celma, C; Bentaher, A; Bergsland, N; Bernardino, AF; Bernhardt, A; Bhandari, RK; Bhaskaran, K; Bhate, K; Bhattacharjee, A; Bian, X; Bien, EM; Birch, M; Bishara, K; Biswas, JP; Bleha, R; Bocale, R; Bona, S; Boriani, G; Bouyssi, A; Bradley, D; Bravo-Sánchez, MG; Bressan, GC; Brik, A; Brizuela, A; Brockbank, KGM; Buchner, F; Bunc, M; Buscombe, JR; Butler, AJ; Buzaleh, AM; Buzin, MI; Cabrera-Capetillo, CA; Calvo, AM; Camerota, A; Campagna, G; Campisi, M; Cano, K; Cao, HST; Cardellini, S; Carvalho, AP; Carvalho, BCR; Castillo-Baltazar, OS; Cataldo, P; Chai, P; Chakraborty, S; Chalo, DM; Chan, MY; Chander, S; Changbunjong, T; Chappuis, CJF; Chee, RCH; Chen, C; Chen, CJ; Chen, E; Chen, M; Chen, X; Chen, Y; Cheng, HT; Cheng, MC; Cheow, HK; Chi, Y; Chirikova, NK; Chiu, SH; Cho, G; Cho, HR; Cho, S; Cho, SJ; Choe, A; Choe, YH; Chun, BS; Chun, Z; Cinque, A; Ciopec, M; Cladas, Y; Cleary, SP; Clermont, O; Cléroux, M; Cockburn, J; Collares, FM; Colombini-Ishikiriama, BL; Conn, BN; Cortina, JL; Cox, DRA; Crini, G; Croker, R; Cursaru, DL; Curtis, HJ; da Silva, KJG; Dalla Costa, T; Davy, S; de Araújo, BV; de Cassia Ribeiro Gonçalves, R; de Gaetano, F; de Gregorio, C; de Oliveira, MG; De Vera, MAT; de Vos, M; de-la-Fuente, I; Dell'Oca, I; Delles, M; Déméautis, T; Dempster, M; Deng, YH; Denisenko, Y; Descombes, C; Desideri, G; Devarbhavi, H; Devouassoux, G; Di Bella, G; Di Marco, F; Diao, Y; Dias, BB; Dilgin, Y; Dimopoulou, I; Dionísio, TJ; Dobrovic, A; Dokin, ES; Dolby, T; Dong, X; Dong, Y; Dou, SX; Douglas, IJ; Dousset, S; Du, Z; Duan, M; Duan, SB; Duke-Williams, O; Duteanu, N; Dutertre, S; Dutta, S; Dwyer, MG; Ebenbauer, J; Eggo, RM; El-Mordy, FMA; Elbhnsawi, NA; Elrehany, MA; Elshewemi, SS; Elwakil, BH; Emadzadeh, D; Eraso, E; Ermolenko, E; Erten, K; Ettorre, E; Evans, D; Evans, SJ; Faheem, M; Fallanza, M; Faramarzi, M; Faria, FAC; Faro, DC; Fatma, YS; Fazil, S; Feng, Y; Ferguson, J; Fernandes, MH; Fernández-Domínguez, M; Ferrari, LAL; Ferraz, EP; Ferreira, LC; Ferri, C; Fikry, M; Floris, M; Forbes, H; Fotouh, B; Franke, K; Freitas, AC; Freitas, GP; Frieboes, HB; Fu, B; Fu, Y; Fukina, DG; Fukuda, DH; Fukunaga, K; Fulham, GJ; Furlan, L; Furtado Mesa, M; Furtunescu, FL; Gabbieri, D; Ganash, M; Gebers, JC; Gehman, V; Ghaedi, A; Ghazali, NSM; Ghebrekristos, Y; Gil, J; Gilbert, NM; Gimenes, R; Giordano, L; Glehen, O; Godeau, C; Goh, SK; Goldacre, B; Gomes, AM; Gomes, MPO; Gomes, PS; Gomes, RMODS; Gómez-Coma, L; Grenho, L; Gu, Q; Gu, T; Gu, YC; Guiducci, V; Guillemin, JP; Guo, W; Guo, YW; Gur, E; Guridi, A; Guzmán-López, A; Gvozdenko, T; H Elmaidomy, A; Hagar, M; Haider, S; Han, JM; Hanratty, J; Hans, R; Haque, N; Harharah, HN; Harharah, RH; Harper, S; Hasegawa, N; Hassanin, AH; Hastuti, YP; Hatem, AE; He, R; He, Y; Heinemann, C; Heinmaa, I; Heinzl, F; Helfer, VE; Hester, F; Hickman, G; Hill, MA; Hill, WG; Hintze, V; Ho, JSY; Ho, LY; Hoang, T; Holzer, I; Houbraken, J; Hsu, CN; Hu, J; Hu, X; Hu, Y; Hua, T; Huang, Z; Hulme, WJ; Hunter, A; Ianăşi, C; Ibañez, R; Iezzi, R; Iliuță, L; Im, YM; Imran, M; Inglesby, P; Inguimbert, N; Iqbal, A; Izawa, N; Jahaj, E; Jain, S; Jakimovski, D; Jalal, MM; Jaroszuk-Ściseł, J; Jasim, DJ; Jauregizar, N; Javle, MM; Jędryczka, M; Ji, H; Jiang, Y; Jin, J; Johnson, NT; Joshi, S; Jullok, N; Kachapulula, PW; Kaczmarek, J; Kaczmarek-Szczepańska, B; Kadota, K; Kaji, M; Kakeji, Y; Kakizoe, S; Kakudidi, E; Kalitukha, L; Kamata, H; Kang, YJ; Kapinos, AA; Karakaya, S; Kashchenko, NI; Kasyanov, S; Kataky, R; Katati, B; Kato, G; Katsina, AU; Kaya, A; Kaya, H; Kazarina, OV; Ke, Y; Keenan, C; Keilson, JM; Keshavan, A; Keskinidou, C; Khalifa, MA; Khan, R; Khan, S; Kim, D; Kim, K; Kim, MS; Kim, SM; Kim, WH; Kim, Y; Kim, YJ; Kishimura, H; Kitagawa, RR; Klemenkova, ZS; Kloss, F; Kobayashi, N; Kohlhoff, M; Kong, WKF; Konsek, H; Kornaros, M; Kotanidou, A; Kovacs, S; Kraska, J; Kruppke, B; Kumagai, Y; Kumar, S; Kumari, R; Kuruva, V; Kuster, RM; Kusumoto, T; Kutyła, M; Kwon, JH; Kwon, SH; Kwong, KY; Kyser, AJ; Lackner, M; Lass-Flörl, C; Lauri, C; Lavandera, JV; Lee, BH; Lee, ECY; Lee, HJ; Lee, J; Lee, PS; Lee, S; Lee, SE; Lee, SY; Lefort, F; Leite, JPV; Leo, G; Leonard, R; Leow, AST; Lepori, N; Leyden, K; Leys, L; Ležaić, L; Li, D; Li, H; Li, J; Li, S; Li, TYW; Li, X; Li, XH; Li, Y; Li, Z; Li, ZH; Liao, S; Liaqat, K; Lim, H; Lin, BS; Lin, MY; Lin, NH; Lin, X; Lin, Y; Liu, C; Liu, H; Liu, HK; Liu, HX; Liu, P; Liu, R; Liu, T; Liu, X; Liu, Y; Lock, GA; Lokaj, G; Lopes, HB; Losi, V; Lotsios, NS; Low, KE; Lu, Z; Luhana, S; Luo, X; Luo, XQ; Lutz, MB; Lysova, AA; Lyssenko, KA; Macit, M; MacIver, B; MacKenna, B; Magalhães, GAP; Magnavacchi, P; Mahadevan, J; Mahboubi, A; Maher, SA; Mahipal, A; Mahmoud, MY; Maithel, SK; Makhtar, MMZ; Makurat-Kasprolewicz, B; Malysheva, YB; Mansourizadeh, A; Marek, EJ; Maresca-Fichter, H; Martin, JT; Maslov, AA; Mastora, Z; Mastroiacovo, D; Mastropetros, SG; Matei, D; Mathur, R; Matos, AO; Matsuda, Y; Maurya, SK; Mayor, Á; Mayrhofer, D; Mazzuco, AC; McCaffrey, J; McClure, T; McDonald, HI; Mchunu, NP; McLaggan, D; Mehrkar, A; Meilik, B; Melito, VA; Mellem, J; Mengozzi, A; Menotti, J; Mesquita, V; Miao, Z; Mihai, S; Miller, S; Minassian, C; Mirabile, A; Mitra, S; Mladin, G; Mo, Z; Moawad, H; Mohamed, EM; Mohammed, TJ; Mohanlall, V; Mohyeldin, RH; Moldovan, H; Monneret, G; Monopoli, DE; Monte, IP; Monteiro, JRB; Morgante, V; Mori, M; Morin-Crini, N; Morita, A; Morton, CE; Mrak, M; Muhammed, AP; Mulick, A; Muralidharan, V; Murthy, P; Muselli, M; Mustafa, S; Mysore Visweswariah, A; Nagao, G; Naicker, S; Nakagawara, K; Namgoong, B; Namkoong, H; Namukobe, J; Nasir, AA; Nasreen, SA; Natarajan, P; Nchiozem-Ngnitedem, VA; Necozione, S; Negrea, A; Negrea, P; Ngubane, S; Nguyen, TT; Nicke, A; Nightingale, E; Nistor, CL; Nitsch, D; Njapau, H; Noman, M; Novgorodtseva, T; Nowak, A; O'Connor, SR; Ofoe, R; Oh, K; Oh, TH; Oki, E; Olama, ZA; Olennikov, DN; Oliveira, GM; Omar, D; Ong, SJ; Orfanos, SE; Origa-Oryem, H; Orita, H; Ortiz, I; Ota, M; Ott, J; Otvagina, KV; Pacheco, N; Pacheco, RR; Padmanabhan, D; Pagan, JD; Pagnotta, PA; Palangi, V; Palanisamy, G; Palanisamy, K; Palanisamy, S; Pan, SG; Panaitescu, E; Pang, X; Panoutsakopoulos, V; Parera, VE; Park, JI; Park, JS; Park, SW; Park, Y; Park, YS; Parkash, O; Parry, J; Parry, JP; Paul, SK; Pavšič, N; Pałubicka, A; Persat, F; Petriz-Prieto, MA; Petukhov, AN; Pham, T; Pillay, S; Poh, KK; Ponomarev, II; Pontons-Melo, JC; Posa, A; Powell, E; Priya, AK; Punekar, R; Puppin Rontani, RM; Purushottam, M; Pusphanathan, K; Qi, JY; Qin, J; Qin, Z; Qiu, B; Qiu, X; Quattrini, G; Quindós, G; Qureshi, F; Rabbany, MA; Rac-Albu, M; Rac-Albu, ME; Rădulescu, BC; Rafatullah, M; Rajab, TK; Rajna, S; Ramanathan, M; Rao, D; Raviglione, D; Razorenov, DY; Redd, MJ; Rehman, W; Reig, M; Rentsch, CT; Ribeiro, LMS; Robles, D; Rocchi, S; Rocha, FG; Rodrigues, C; Rodrigues, LA; Rodrigues, RP; Roh, GH; Ronowska, A; Root, A; Rosa, AL; Rossi, R; Roy, S; Roy, VC; Rupji, M; Saber, EA; Sadarat, F; Saed, Y; Saeed, WS; Saeki, H; Saha, B; Saiwichai, T; Sakowicz-Burkiewicz, M; Sampedro, T; Sands, K; Santos, CF; Sari, M; Sathi, FA; Sauro, S; Sazanova, TS; Scafa-Udriște, A; Schoustra, SE; Schultze, A; Seo, DJ; Sevillano, E; Sezmis, G; Sgura, FA; Shah, NNAK; Shani, N; Shankarappa, B; Sharkey, LM; Sharma, VK; Sharp, C; Shehata, N; Shelton, N; Shieh, PB; Shimokawa, M; Shin, J; Shin, SH; Shin, YN; Shin, YR; Shipilova, A; Shoparwe, NF; Shukor, H; Sia, CH; Siddiqui, MH; Siddiqui, MR; Siena, V; Signore, A; Silwane, B; Siqueira-Sandrin, VS; Siregar, A; Sirignano, P; Sit, NW; Skidmore, S; Skupov, KM; Smeeth, L; Smoczer, C; Smolyanskiy, E; Sohn, H; Solodeev, I; Solovyev, A; Şomoghi, R; Song, F; Song, H; Song, Z; Souf, YM; Sousa, SC; Souza, MT; Steinbach-Rankins, JM; Stockton, J; Stout, JR; Su, K; Su, MZ; Suarez-Lopez, YA; Sukkurd, R; Sultanov, R; Sun, Y; Sun, Z; Supernak, M; Supriyono, E; Suroshe, SS; Suvorov, SS; Svera M Ianăşi, P; Switchenko, JM; Syarif, NY; Synytsya, A; Taherzadeh, MJ; Tain, YL; Tamburino, C; Tammam, OY; Tan, BYQ; Tan, H; Tan, S; Tanaka, H; Tang, R; Tang, X; Tang, Z; Taurino, M; Tazare, J; Teresi, L; Testro, A; Thanasoponkul, W; Thangarasu, S; Thavaselvam, D; Theodoro, RC; Theron, G; Thomas, RH; Thomson, JJ; Tian, X; Tian, Y; Tomaszewski, CA; Tomlinson, LA; Torres, CMME; Tóth, M; Trecourt, A; Trevisani, F; Trimarchi, G; Tristán, C; Truong, VK; Tsigkou, K; Tsutsumi, S; Ubukata, Y; Uehara, H; Uwamino, Y; Vahedi-Shahandashti, R; Valberg, SJ; Valderrama, C; Valdovinos-García, EM; Valsecchi, D; van Diepeningen, AD; van West, P; Vargas-Osuna, E; Vassall, M; Vassilaki, N; Vassiliou, AG; Vecino, X; Velez-Irizarry, D; Venkatesh, YN; Vignali, L; Virdis, A; Viswanath, B; Voisin, AS; Volkova, YA; Vorotyntsev, AV; Vorotyntsev, IV; Vtyurina, ES; Vu, DH; Waldridge, B; Walker, AJ; Wallon, M; Wang, B; Wang, G; Wang, H; Wang, J; Wang, LJ; Wang, S; Wang, T; Wang, X; Wang, Z; Warren, RM; Warren-Gash, C; Wei, SH; Weinstock-Guttman, B; Wekwejt, M; Wessjohann, LA; Wiesmann, HP; Williams, ZJ; Williamson, EJ; Wilson, M; Wing, K; Wong, AY; Wong, BKL; Woodward, S; Wozniak, KL; Wu, C; Wu, K; Wu, S; Wu, Y; Xiang, D; Xie, H; Xiong, X; Xu, C; Xu, H; Xu, J; Xu, WH; Xu, Y; Xun, T; Yamaguchi, S; Yan, P; Yan, W; Yan, Z; Yang, B; Yang, F; Yang, L; Yao, XB; Yasui, H; Yenesew, A; Yeo, LLL; Yeo, TC; Yi, S; Yin, F; Yip, JWL; Yoon, SH; Yoon, SJ; Yoshida, M; Yoshizumi, T; Young, LA; Yu, C; Yu, DD; Yu, F; Yu, H; Yu, JD; Yu, NJ; Yu, X; Yuan, Y; Yurenko, A; Yusof, YA; Zahedipoor, A; Zahran, EM; Zainuddin, NI; Zanatta, AC; Zanotto, ED; Zanozin, ID; Zavascki, AP; Zenke, M; Zhang, F; Zhang, G; Zhang, H; Zhang, J; Zhang, L; Zhang, MX; Zhang, NY; Zhang, Q; Zhang, W; Zhang, X; Zhang, XM; Zhao, F; Zhao, Q; Zhao, R; Zhao, Y; Zheng, J; Zheng, S; Zhou, L; Zhou, X; Zhu, H; Zivadinov, R; Žižek, D; Zuccoli, JR; Zwaan, BJ | 1 |
| Acramel, A; Chouquet, T; Goldwirt, L; Jouenne, F; Mourah, S; Plé, A; Sauvageon, H | 1 |
| Cao, P; Gong, Y; Liang, B; Liu, Y; Lu, Y; Luo, C; Wang, J; Wang, Y; Xu, Y; Xue, J; Yan, T; Zhou, L; Zhou, X; Zhou, Y | 1 |
| Akslen, LA; Anandan, S; Bischof, K; Bjørge, L; Fosse, V; Gjertsen, BT; Karlsen, IT; Kleinmanns, K; McCormack, E; Popa, M | 1 |
| Fan, Z; He, Y; Li, J; Li, Y; Ouyang, T; Wang, L; Wang, T; Xie, Y | 1 |
| Dave, JK; Eisenbrey, JR; Forsberg, AI; Forsberg, F; Fox, TB; Halldorsdottir, VG; Liu, JB; Machado, P; Marshall, A; Merton, DA | 1 |
| Asher, R; Baron-Hay, S; Gibbs, E; Giuffre, B; Khasraw, M; Mukaro, V; Murphy, C; Tobler, R; West, L | 1 |
| Ai, W; Chen, Y; Huang, J; Li, D; Li, G; Si, L; Wu, S; Zhao, G | 1 |
| Andriguetti, NB; Antunes, MV; Costa, JL; da Cunha, KF; Hahn, RZ; Kluck, HM; Linden, R; Lizot, LF; Raymundo, S; Schwartsmann, G; Vilela, RMM | 1 |
| Bahra, M; Neumann, CCM; Pratschke, J; Reutzel-Selke, A; Sauer, IM; Schmuck, RB; Seidel, E; von Hörschelmann, E | 1 |
| Ceballos, L; Freije, A; Gandarillas, A; García-Reija, F; Morales-Angulo, C; Obeso, S; Sanz, JR; Sanz-Gómez, N | 1 |
| Chen, JJ; Guo, C; Han, YL; Hu, JD; Jiang, B; Shi, MZ; Xiao, X; Xing, TY; Yang, J; Zhu, J | 1 |
| Artemov, D; Kato, Y; Zhu, W | 1 |
| Huang, Y; Wang, P; Wei, Y; Xue, Z; Ye, Y; Zhao, L | 1 |
| Bai, L; Cao, W; He, Z; Li, X; Lian, H; Liu, Y; Sun, J; Wang, Y | 1 |
| Albrecht, BJ; Bartlett, MG; Gao, M; Li, P; Weng, HR; Yan, X | 1 |
| Gao, YT; Li, M; Li, N; Li, XG; Sun, YC; Tian, HM; Wang, XB; Wu, LY; Zhang, W; Zhao, D | 1 |
| Alvarez-Ossorio, MP; Bellido, FM; de Lezo Cruz-Conde, JS; de Lezo Herrerosde Tejada, JS; Fernández-Aceytuno, AM; Pavlovic, D; Pineda, SO; Romero Moreno, MÁ; Saint-Gerons, JM; Toledano Delgado, FJ | 1 |
| Chen, W; Feng, J; Gao, S; Miao, H; Tao, X; Yun, Y; Zhang, F; Zhou, J | 1 |
| Hulshoff, JB; Plukker, JT; Smit, JK; van der Jagt, EJ | 1 |
| Cho, J; Choi, NC; Sharp, GC; Shusharina, N | 1 |
| Cortot, A; Hossein-Foucher, C; Olivier, A; Petyt, G; Scherpereel, A | 1 |
| Bellile, E; Bradford, CR; Carey, T; Chanowski, EJ; Chepeha, DB; Chinn, SB; Eisbruch, A; Gallagher, KK; Ibrahim, M; McHugh, JB; Moyer, JS; Prince, ME; Spector, ME; Vainshtein, J; Walline, HM; Wolf, GT; Worden, FP | 1 |
| Cho, H; Kim, JH; Kim, S; Kim, SW; Kim, YT; Lee, M; Nam, EJ | 1 |
| Barar, J; Hejazi, MS; Samadi, N; Sharifi, S | 1 |
| Ahmed, AA; Dobson, PJ; Goldsmith, J; Stratford, MR; Townley, HE; Zheng, Y; Zheng, YY | 1 |
| Aihara, H; Ando, K; Kuramitsu, S; Nobuyoshi, M; Soga, Y; Tomoi, Y | 1 |
| Alvandi, H; Hassanpour, F; Sadeghi, Z; Salavati, H; Taei, M | 1 |
| de Bruijn, P; de Graan, AJ; Elbouazzaoui, S; Martens, JW; Mathijssen, RH; Nieuweboer, AJ; Smid, M; van Schaik, RH | 1 |
| Li, FY; Li, J; Xing, XZ; Xing, YJ; Zhang, QL | 1 |
| Boellaard, R; de Jong, EE; Dingemans, AC; Groen, HJ; Hoekstra, OS; Lambin, P; Leijenaar, RT; Smit, EF; Troost, EG; van der Noort, V; van Elmpt, W | 1 |
| Chen, J; Gao, Y; Guo, S; Wang, Y; Xie, H; Zhang, X | 1 |
| Cesca, M; Davoli, E; Decio, A; Ferrari, M; Frapolli, R; Fuso Nerini, I; Giavazzi, R; Giordano, S; Licandro, SA; Maiezza, M; Maurizio, D; Morosi, L; Zucchetti, M | 1 |
| Alrushaid, S; Davies, NM; Gu, X; Lakowski, TM; Malhi, S; Stesco, N | 1 |
| Ameshima, S; Demura, Y; Ishizaki, T; Mizuno, S; Morikawa, M; Okazawa, H | 1 |
| Chung, HH; Kang, SB; Kim, HS; Kim, JW; Park, NH; Song, YS | 1 |
| Cao, J; Qu, J; Straubinger, RM; Wang, H; Yu, H | 1 |
| Fu, YJ; Hua, X; Jiang, SG; Wang, JT; Wang, Z; Zhang, L; Zhang, Y; Zu, YG | 1 |
| Chen, GH; Zhang, SQ | 1 |
| Efferth, T; Fu, Y; Gu, C; Li, S; Luo, H; Sun, R; Wang, Y; Zhang, L; Zu, Y | 1 |
| Abraham, D; Bahr, RD; Hamirani, YS; Jibrin, I; Merriman, B; Wenz, C | 1 |
| Beh, CW; Ee, PL; Ong, ZY; Seow, WY; Wang, Y; Yang, YY; Zhang, Y | 1 |
| Gaspar, JR; Qu, J; Straubinger, NL; Straubinger, RM | 1 |
| Bai, A; Beckham, TH; Bielawska, A; Bielawski, J; Cheng, JC; Elojeimy, S; Garcia, N; Gault, CR; Hammouda, HM; Hannun, YA; Keane, TE; Li, J; Liu, X; Mahdy, AE; McPherson, AS; Meacham, WD; Norris, JS; Saad, A; Taha, MI; Turner, LS | 1 |
| Ai, CZ; Ge, GB; He, YQ; Liu, XB; Wang, ZT; Yang, L; Zhang, R; Zhang, YY | 1 |
| Chun, C; Kim, SY; Lee, SM; Song, SC; Yang, HK | 1 |
| Avril, N; Avril-Sassen, S; Dose-Schwarz, J; Jänicke, F; Lebeau, A; Mahner, S; Schwaiger, M; Tiling, R; Untch, M; Weber, C | 1 |
| Baggerly, K; Coutant, C; Kim, YC; Lee, JK; Pusztai, L; Qi, Y; Rouzier, R; Symmans, WF; Theodorescu, D | 1 |
| Bang, YJ; Choi, SH; Im, SA; Kim, J; Kim, JH; Kim, YH; Lee, KH; Lee, KW; Oh, DY; Yang, SH | 1 |
| Bermingham, S; McMahon, GP; O'Connor, R; Regan, F | 1 |
| Chignola, R; Dalla Pellegrina, C; Tomelleri, C | 1 |
| Andrews, GA; Fooshee, DR; Frederick, MJ; Galer, C; Milas, ZL; Morrow, PK; Myers, JN; Sano, D; Zhao, M | 1 |
| Bui-Nguyen, TM; Geller, MA; Ramakrishnan, S; Rogers, LM | 1 |
| Gu, Z; Shen, Y; Wang, M; Xu, Q; Xu, S; Yin, X; Zhang, L; Zhang, N | 1 |
| Ahn, S; Dalton, JT; Li, CM; Lu, Y; Miller, DD; Narayanan, R | 1 |
| Chen, L; Wang, X; Wei, Y; Zheng, H; Zhu, Z | 1 |
| Chen, Y; Gao, H; Liu, W; Liu, Y; Zuo, J | 1 |
| Chang, QY; Li, M; Li, XG; Li, YF; Liu, J; Song, PP; Tian, HM; Wang, XB; Wu, LY; Zhang, W; Zhao, D | 1 |
| Baba, Y; Kim, SJ; Kishi, K; Naoi, Y; Noguchi, S; Taguchi, T; Tamaki, Y; Tanei, T; Tominaga, N; Tsunashima, R | 1 |
| Ren, JM; Sun, Q; Wang, CP; Yin, LX; Zhang, ZQ; Zhao, X | 1 |
| Chang, QY; Li, M; Li, XG; Li, YF; Liu, J; Song, PP; Tian, HM; Wang, XB; Wu, LY; Zhang, LF; Zhang, W; Zhao, D | 1 |
| Foti, RS; Rock, DA; VandenBrink, BM; Wahlstrom, JL; Wienkers, LC | 1 |
| Cheng, YC; Dutschman, GE; Li, X; Zhang, W | 1 |
| Bahri, S; Butler, JA; Carpenter, PM; Chen, JH; Feig, SA; Hsiang, DJ; Kuzucan, A; Lane, KT; Lin, M; Mehta, RS; Nalcioglu, O; Su, MY; Yu, HJ | 1 |
| Beijnen, JH; Hendrikx, JJ; Hillebrand, MJ; Rosing, H; Schellens, JH; Schinkel, AH; Thijssen, B | 1 |
| Arlinghaus, LR; Atuegwu, NC; Chakravarthy, BA; Gore, JC; Li, X; Welch, EB; Yankeelov, TE | 1 |
| Kumar, SV; Saha, RN; Srinath, S | 1 |
| Castañeda, G; Contento, AM; Muñoz, L; Rodríguez, J | 1 |
| Applegate, RJ; Cao, S; Cutlip, DE; Hattori, K; Hermiller, JB; Hou, L; Kereiakes, DJ; Pervaiz, MH; Sood, P; Stone, GW; Su, X; Sudhir, K; Wang, J; Yaqub, M | 1 |
| Cittadini, G; Costantini, S; Mammoliti, S; Marchiolè, P; Moioli, M; Sala, P; Valenzano Menada, M | 1 |
| Gao, J; Li, Y; Lu, Z; Shen, L; Yu, J | 1 |
| Allan, AL; Hedley, BD; Keeney, M; Lowes, LE | 1 |
| De Wever, O; Fransen, E; Lardon, F; Limame, R; Pauwels, B; Pauwels, P; Peeters, M; Wouters, A | 1 |
| Baumann, K; Belau, A; Bentley, J; Berton-Rigaud, D; Brown, C; Canzler, U; Friedlander, M; Gebski, V; Kristensen, G; Kurzeder, C; Ledermann, JA; Lee, CK; Lord, SJ; Nankivell, M; Parma, G; Pfisterer, J; Pisano, C; Plante, M; Pujade-Lauraine, E; Schauer, C; Simes, RJ; Skeie-Jensen, T; Swart, AM; Vergote, I | 1 |
| Akervall, J; Galoforo, S; Geddes, TJ; Grénman, R; Marples, B; Thibodeau, BJ; Wilson, GD | 1 |
| Jiang, L; Mason, RP; McColl, RW; Tripathy, D; Weatherall, PT | 1 |
| Demura, Y; Kimura, H; Morikawa, M; Okazawa, H; Tsuchida, T; Umeda, Y | 1 |
| Hariki, H; Hiranuma, N; Hirata, K; Inoue, T; Kawamori, H; Kozuki, A; Matsumoto, D; Nagoshi, R; Nakagawa, M; Nishio, R; Osue, T; Otake, H; Shinke, T; Shite, J; Taniguchi, Y | 1 |
| Choudhury, H; Gorain, B; Karmakar, S; Pal, TK | 1 |
| Bauer, J; Besenval, M; Caldiera, S; Cuvier, C; Lebecq, A; Marty, M; Monnerat, C; Pérard, D; Semiond, D; Sessa, C; Van Den Bosch, S | 1 |
| Bombardelli, E; Colombo, T; D'Incalci, M; Frapolli, R; Fruscio, R; Morazzoni, P; Riva, A; Zaffaroni, M; Zucchetti, M | 1 |
| Bachmann, N; Barberi-Heyob, M; Merlin, JL | 1 |
| Ackland, SP; Clarke, S; Garg, MB; Millward, MJ; Rischin, D; Smith, J; Toner, GC; Zalcberg, J | 1 |
| Cosio, S; Gadducci, A; Genazzani, AR; Muraca, S | 1 |
| Egorin, MJ; Parise, RA; Ramanathan, RK; Zamboni, WC | 1 |
| Friess, T; Osl, F; Scheuer, WV; Schneider, T; Stockinger, H | 1 |
| Hudis, C | 1 |
| Bernard-Marty, C; Bissery, MC; Cardoso, F; Di Leo, A; Dumontet, C; Fellous, A; Gancberg, D; Larsimont, D; Paesmans, M; Piccart, MJ; Treilleux, I | 1 |
| Chan, YW; Ho, PC; Lee, HS; Vaddi, HK; Wang, LZ; Yung, CS | 1 |
| Baayen, HC; Barkhof, F; Boogerd, W; Castelijns, JA; Elkhuizen, PH; Heimans, JJ; Postma, TJ; Uitdehaag, BM; Vos, MJ | 1 |
| Aubert, C; Bun, H; Bun, SS; Catalin, J; Ciccolini, J | 1 |
| Chen, W; Morais, S; Mulchandani, A; O'Malley, S | 1 |
| Goromaru, T; Hirakawa, T; Itoh, Y; Nakano, H; Oishi, R; Sendo, T; Takasaki, S; Yahata, H | 1 |
| Mohamed, F; Sugarbaker, PH | 1 |
| Coker, A; Kamer, E; Ozer, E; Ozkara, E; Ozzeybek, T; Sevinç, AI | 1 |
| Gallo, JM; Guo, P; Li, S; Ma, J | 1 |
| Lane, SR; Ross, GA; ten Bokkel Huinink, W | 1 |
| Baggerly, KA; Drake, RR; Esteva, FJ; Gregory, BW; Hortobagyi, GN; Koomen, J; Kuerer, HM; Laronga, C; Peng, B; Pusztai, L; Semmes, OJ; Symmans, WF; Vlahou, A; Wagner, P; Wright, GL | 1 |
| Kalb, EN; Lazo, JS; Vogt, A | 1 |
| Kishida, T; Komiyama, M; Mori, T; Noguchi, M; Noguchi, Y; Ohnishi, M; Sawaguchi, K; Yabushita, H | 1 |
| Lambert, WE; Mortier, KA; Verstraete, AG; Zhang, GF | 1 |
| Dilek, TU; Guner, H; Oktem, M; Tiras, MB | 1 |
| Grann, VR; Hershman, D; Jacobson, JS; McBride, R; Mitra, N; Neugut, AI; Sundararajan, V | 1 |
| Devries, A; Haidenberger, A; Lukas, P; Nevinny-Stickel, M; Saurer, M; Seppi, T; Skvortsov, S; Skvortsova, I | 1 |
| Ajani, JA; Bresalier, R; Correa, AM; Erasmus, JJ; Komaki, R; Macapinlac, H; Maish, M; Munden, RF; Putnam, JB; Rice, D; Roth, JA; Smythe, WR; Swisher, SG; Vaporciyan, AA; Walsh, GL; Wu, TT | 1 |
| Dolatyari, L; Ghassempour, A; Rassouli, A; Talebi, M; Talebpour, Z | 1 |
| Beijnen, JH; Kemper, EM; Nan, LG; Ouwehand, M; Rosing, H; Stokvis, E; van Tellingen, O | 1 |
| Ahmad, A; Ahmad, I; Guo, W; Johnson, JL; Khan, S | 1 |
| Banks, RE; Ferguson, RE; Harnden, P; Jackson, SM; Joyce, AD; Morrison, EE; Patel, PM; Phillips, RM; Selby, PJ; Stanley, AJ | 1 |
| Jordan, MA; Wilson, L | 1 |
| Dan, S; Fukui, Y; Nakamura, T; Nakatsu, N; Yamazaki, K; Yamori, T; Yoshida, Y | 1 |
| Chen, W; Kim, JY; Mulchandani, A; O'Malley, S | 1 |
| Gao, S; Iyer, SS; Karnes, HT; Kellogg, GE; Zhang, ZP | 1 |
| Gildehaus, FJ; Goldbrunner, R; Holtmannspötter, M; Kreth, FW; Pöpperl, G; Tanner, P; Tatsch, K; Tonn, JC | 1 |
| Marzocchi, A; Saia, F; Serruys, PW | 1 |
| Cetina, L; Duenas-Gonzalez, A; Oñate-Ocaña, LF; Taja-Chayeb, L; Trejo-Becerril, C; Vanoye-Carlo, A | 1 |
| Chao, DY; Fu, J; Shi, XY; Tian, HM; Wang, JW; Wu, LY; Zhang, K; Zhang, W | 1 |
| Avril, N; Bader, M; Dose Schwarz, J; Hemminger, G; Jänicke, F; Jenicke, L | 1 |
| Lambert, WE; Mortier, KA; Renard, V; Van Belle, S; Van Gussem, A; Verstraete, AG | 1 |
| Beijnen, JH; Rosing, H; Schellens, JH; Stokvis, E; Thijssen, B; Vainchtein, LD | 1 |
| Chi, SC; Kim, SC; Lee, JW; Park, ES; Yu, J | 1 |
| Chen, T; Chu, ZH; Liu, JP; Ou, QJ; Wang, J; Zhao, HY | 1 |
| Edinboro, LE; Gao, S; Karnes, HT; Ngoka, LC; Zhang, ZP | 1 |
| Argyriou, AA; Chroni, E; Iconomou, G; Kalofonos, HP; Katsoulas, G; Koutras, A; Makatsoris, T; Papapetropoulos, S; Polychronopoulos, P | 1 |
| Cengiz, A; Doğusoy, G; Ertürk, S; Gümüştaş, K; Kafadar, Y; Ozgüroğlu, M; Temiz, M; Yüceyar, S | 1 |
| Aamdal, S; Andersen, A; Brunsvig, PF; Kristensen, GB; Olsen, H; Warren, DJ | 1 |
| Gibson, SB; Henson, ES; Hu, X | 1 |
| Moussa, I | 1 |
| Ji, HY; Kim, MS; Lee, GS; Lee, HS; Paek, IB | 1 |
| Boellaard, R; Crezee, H; Hoekstra, OS; Hulshof, MC; Omloo, JM; Sloof, GW; ten Kate, FJ; van Lanschot, JJ; Vervenne, WL; Westerterp, M | 1 |
| Chu, ZE; Figg, WD; Gardner, ER; Liau, CT; Sparreboom, A | 1 |
| Fu, Y; Li, Q; Li, S; Schwarz, G; Sun, R; Zu, Y | 1 |
| Anderson, K; Booser, D; Buzdar, AU; Dempsey, PJ; Gómez, HL; Hess, KR; Hortobagyi, GN; Ibrahim, N; Mejia, JA; Pusztai, L; Ross, JS; Rouzier, R; Sneige, N; Symmans, WF; Theriault, RL; Valero, V; Vidaurre, T | 1 |
| Briel, M; Bucher, HC; Nordmann, AJ | 1 |
| Cheng, JX; Kang, E; Kwon, IK; Park, K; Robinson, J; Wang, H | 1 |
| Fujiwara, M; Ito, S; Ito, Y; Kodera, Y; Koike, M; Mochizuki, Y; Nakao, A; Nakayama, G; Ohashi, N; Yamamura, Y | 1 |
| Alcaraz, AA; Bane, S; Cegelski, L; Johnson, SA; Kingston, DG; Metaferia, B; O'Connor, RD; Paik, Y; Ravindra, R; Schaefer, J; Shanker, N; Snyder, JP; Tang, S; Yang, C | 1 |
| Nakashima, K; Nakashima, MN; Ogino, S; Wada, M; Yonemoto, H | 1 |
| Furukawa, T; Hata, K; Hirai, I; Kawago, M; Kokawa, Y; Nakamura, R; Ohta, F; Okamura, Y; Oura, S; Tamaki, T; Tanino, H; Yoshimasu, T | 1 |
| Ito, N; Kamoto, T; Ogawa, O; Shang, D | 1 |
| Finn, AV; Gold, HK; Joner, M; Kolodgie, FD; Mont, EK; Nakazawa, G; Virmani, R | 1 |
| Kiessling, F; Kobayashi, M; Koike, K; Richter, GM; Semmler, W; Stampfl, U; Stiller, W | 1 |
| Bosmans, J; De Graeve, D; De Ridder, A; Mahieu, J; Vrints, C | 1 |
| Azambuja, E; Cardoso, F; Colozza, M; Durbecq, V; Larsimont, D; Piccart-Gebhart, M; Rosa, DD | 1 |
| Baick, CH; Butler, JA; Hsiang, DJ; Lane, KT; Mehta, RS; Su, MY; Yamamoto, M | 1 |
| Clement, MV; Lee, SC; Pervaiz, S; Sim, N; Yadav, SK | 1 |
| Akiyama, J; Hayashi, Y; Iwashita, R; Kobayakawa, M; Masaki, N; Nagaoki, Y; Nagata, N; Nozaki, Y; Oshima, T; Sako, A; Sakurai, T; Tamegai, Y; Uemura, N; Umeda, N; Watanabe, M; Yago, Y | 1 |
| Eisele, DW; Glastonbury, CM; Lin, D; Rafaelian, O; Wang, SJ | 1 |
| Arcoleo, F; Cillari, E; Enia, F; Lo Giudice, A; Lo Mauro, R; Picone, A; Raspanti, G; Schirosa, M | 1 |
| Au, JL; Walsh, CT; Wei, Y; Wientjes, MG | 1 |
| Awaya, T; Iida, S; Matsubara, K; Ohtaki, K; Ono, T; Satomi, M; Shimizu, K; Suno, M; Tasaki, Y; Umetsu, N; Yamada, T | 1 |
| Kastrati, A | 1 |
| Adelstein, DJ; Mekhail, TM; Murthy, S; Rice, TW; Saxton, JP; Suh, JH; Videtic, GM | 1 |
| Bellet, RE; Creekmore, AN; Egorin, MJ; Ellis, MJ; Fracasso, PM; Fu, CJ; Gao, F; Goodner, SA; Govindan, R; Linette, GP; Pentikis, HS; Picus, J; Tan, BR; Wildi, JD; Zumbrun, SC | 1 |
| Choi, SH; Han, SS; Kang, SB; Kim, JW; Lee, HP; Lee, YK; Park, NH; Song, YS | 1 |
| Mooberry, SL; Moore, RE; Stratman, K | 1 |
| Beijnen, JH; Bekos, EJ; Duncan, GF; Farmen, RH; Gaver, RC; Tay, LK; Willey, TA | 1 |
| Averette, HE; Method, MW; Penalver, MA; Rodriguez, M; Serafini, AN; Sevin, BU | 1 |
| Bissery, MC; Chabot, GG; Lavelle, F; Vrignaud, P | 1 |
| Blaschke, G; Boos, J; Hempel, G; Krümpelmann, S; Lehmkuhl, D | 1 |
| Becagli, P; Messori, A; Tendi, E; Trippoli, S | 1 |
| Elit, LM; Gafni, A; Levine, MN | 1 |
| Loos, WJ; Nooter, K; Sparreboom, A; Stoter, G; Verweij, J | 2 |
| Bonneterre, J; Launois, RJ; Reboul-Marty, JM | 1 |
| de Bruijn, P; Loos, WJ; Nooter, K; Sparreboom, A; Stoter, G; Verweij, J | 1 |
| Beccaglia, P; Broggini, M; D'Incalci, M; Ottoboni, C; Russo, P; Vignati, S; Vikhanskaya, F | 1 |
| Blachon, MF; Catalin, J; Durand, A; Martin, N | 1 |
| Bicamumpaka, C; Pagé, M | 1 |
| Durka, S; Hueber, A; Weller, M | 1 |
| Baker, TR; Blumenson, LE; Eltabbakh, GH; Hempling, RE; Lele, SB; Marchetti, DL; Piver, MS; Recio, FO | 1 |
| Berger, K; Fischer, T; Szucs, TD | 1 |
| Lee, KH; Lee, SH; Yoo, SD | 1 |
| Earle, CC; Evans, WK | 1 |
| Bishop, WR; Izbicka, E; Lawrence, RA; Petit, T; Von Hoff, DD; Weitman, S | 1 |
| Ardizzoni, A; de Cupis, A; Favoni, RE; Grossi, F; Loprevite, M; Merlo, F; Pirani, P | 1 |
| Bombardelli, E; Colombo, T; D'Incalci, M; Frapolli, R; Morazzoni, P; Riva, A; Zucchetti, M | 1 |
| Egodage, KL; Slavik, M; Svojanovsky, SR; Wilson, GS; Wu, J | 1 |
| Avril, N; Dose, J; Graeff, H; Jänicke, F; Kuhn, W; Nährig, J; Römer, W; Sattler, D; Schelling, M; Schwaiger, M; Werner, M | 1 |
| Ah-See, AK; Chilcott, F; Eremin, O; Gilbert, FJ; Heys, SD; Hutcheon, AW; Miller, ID; Payne, S; Sharp, PF; Smith, IC; Waikar, S; Welch, AE; Whitaker, T | 1 |
| Cree, IA; Crohns, C; Felber, M; Hepp, H; Konecny, G; Kurbacher, C; Lude, S; Pegram, M; Untch, M | 1 |
| Ames, FC; Bedi, D; Buzdar, AU; Feig, BW; Fornage, BD; Hunt, KK; Lenert, JT; Mirza, NQ; Ross, MI; Singletary, SE; Tolley, SM; Vlastos, G; Winchester, DJ | 1 |
| Guillemard, V; Saragovi, HU | 1 |
| Hackney, DD; Jiang, W | 1 |
| Goehle, S; Lamb, JR; Ludlow, C; Simon, JA | 1 |
| Blachon, MF; Catalin, J; Ciccolini, J; Durand, A | 1 |
| Fojo, T; Giannakakou, P; Giavazzi, R; Kim, JH; Landoni, F; Lucchini, V; Mayo, JG; Nicoletti, MI; Valoti, G; Zhan, Z | 1 |
| Colombo, T; D'Incalci, M; Fruscio, R; Minoia, C; Sottani, C; Zucchetti, M | 1 |
| O'Meara, AT; Sevin, BU | 1 |
| Mulchandani, A; Sheikh, SH | 1 |
| Kobina, S; Moyano, A; Rubio-Terrés, C; Tisaire, JL | 1 |
| Clegg, A; Hewitson, P; Scott, DA; Sidhu, M; Waugh, N | 1 |
| Burkes, RL; Feld, R; Goodwin, PJ; Kwong, R; Leighl, NB; Shepherd, FA | 1 |
| Mader, RM; Rizovski, B; Steger, GG | 1 |
| Bovik, AC; Ling, J | 1 |
| Baker, SD; Brahmer, JR; Sparreboom, A; Verweij, J; Zhao, M | 1 |
| Ge, GB; He, YQ; Liu, XB; Luan, HW; Wang, ZT; Yang, L; Zhang, YY | 1 |
| Kobayashi, N; Koyama, J; Morita, I; Nobukawa, M; Shimizu, M; Takeuchi, A; Tode, C | 1 |
| Gausterer, C; Stein, C; Stimpfl, T | 1 |
| Augsburger, M; Varlet, V | 1 |
| Feucht, W; Polster, J; Treutter, D | 1 |
14 review(s) available for paclitaxel and Sensitivity and Specificity
| Article | Year |
|---|---|
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Molecular mechanisms of apoptosis and chemosensitivity to platinum and paclitaxel in ovarian cancer: biological data and clinical implications.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Drug Resistance, Neoplasm; Female; Genes, p53; Humans; Molecular Biology; Mutation; Ovarian Neoplasms; Paclitaxel; Platinum; Prognosis; Proto-Oncogene Proteins c-bcl-2; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2002 |
Adjuvant use of taxanes for patients with breast cancer: we see the tip of the iceberg.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Mastectomy, Segmental; Neoplasm Staging; Paclitaxel; Patient Selection; Prognosis; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Survival Analysis; Taxoids; Treatment Outcome; United States | 2002 |
Intraperitoneal taxanes.
Topics: Antineoplastic Agents, Phytogenic; Biological Availability; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Docetaxel; Dose-Response Relationship, Drug; Female; Gastrointestinal Neoplasms; Humans; Infusions, Parenteral; Male; Maximum Tolerated Dose; Paclitaxel; Risk Assessment; Sensitivity and Specificity; Taxoids | 2003 |
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Irinotecan; Life Tables; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Preoperative Care; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Drug Delivery Systems; Drug Resistance, Neoplasm; Drug Synergism; Humans; Microtubule-Associated Proteins; Microtubules; Neoplasms; Paclitaxel; Sensitivity and Specificity; Tubulin; Tumor Cells, Cultured | 2004 |
Drug-eluting stents. The third revolution in percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Disease; Coronary Restenosis; Drug Delivery Systems; Female; Humans; Male; Paclitaxel; Prognosis; Radiography; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Sirolimus; Stents; Treatment Outcome | 2005 |
Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis.
Topics: Aged; Coronary Artery Disease; Drug Implants; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Middle Aged; Paclitaxel; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Sirolimus; Stents; Tubulin Modulators | 2006 |
Vascular responses to drug eluting stents: importance of delayed healing.
Topics: Aged; Angioplasty, Balloon, Coronary; Animals; Biopsy, Needle; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Disease Models, Animal; Endothelium, Vascular; Humans; Immunohistochemistry; Middle Aged; Paclitaxel; Prognosis; Prosthesis Design; Rabbits; Risk Factors; Sensitivity and Specificity; Sirolimus; Stents; Time Factors; Wound Healing | 2007 |
Economic analysis of the use of drug-eluting stents from the perspective of Belgian health care.
Topics: Angioplasty, Balloon, Coronary; Belgium; Coronary Artery Bypass; Coronary Restenosis; Cost-Benefit Analysis; Drug-Eluting Stents; Follow-Up Studies; Humans; Metals; Paclitaxel; Prosthesis Design; Reoperation; Research Design; Retrospective Studies; Sensitivity and Specificity; Sirolimus; Treatment Outcome | 2007 |
HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Mastectomy; Neoplasm Staging; Paclitaxel; Predictive Value of Tests; Prognosis; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Taxoids; Trastuzumab; Treatment Outcome | 2008 |
[A medico-economic evaluation of second line chemotherapy in metastatic breast cancer: comparison between docetaxel, paclitaxel, and vinorelbine].
Topics: Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cost-Benefit Analysis; Docetaxel; Drug Administration Schedule; Female; Humans; Neoplasm Metastasis; Paclitaxel; Quality of Life; Sensitivity and Specificity; Survival Analysis; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 1997 |
Assays for kinesin microtubule-stimulated ATPase activity.
Topics: Adenosine Triphosphate; Animals; Brain Chemistry; Cattle; Colorimetry; Guanosine Triphosphate; Kinesins; Microtubules; Nerve Tissue Proteins; Osmolar Concentration; Oxidation-Reduction; Paclitaxel; Phosphates; Rosaniline Dyes; Sensitivity and Specificity | 2001 |
Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cost of Illness; Cost-Benefit Analysis; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Lung Neoplasms; Paclitaxel; Quality of Life; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 2002 |
27 trial(s) available for paclitaxel and Sensitivity and Specificity
| Article | Year |
|---|---|
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Evaluating the role of magnetic resonance imaging post-neoadjuvant therapy for breast cancer in the NEONAB trial.
Topics: Adult; Aged; Albumins; Australia; Breast Neoplasms; Cohort Studies; Cyclophosphamide; Epirubicin; Female; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Receptor, ErbB-2; Sensitivity and Specificity; Trastuzumab | 2018 |
Pretreatment Pokemon Level as a Predictor of Response to Cisplatin and Paclitaxel in Patients with Unresectable Non-Small Cell Lung Cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; China; Cisplatin; DNA-Binding Proteins; Female; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pneumonectomy; Prognosis; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Survival Rate; Transcription Factors; Treatment Outcome | 2015 |
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Netherlands; Nitroglycerin; Paclitaxel; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Vasodilator Agents | 2017 |
Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Magnetic Resonance Imaging; Mammography; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Mammary | 2010 |
Individualized tumor response testing for prediction of response to Paclitaxel and Cisplatin chemotherapy in patients with advanced gastric cancer.
Topics: Adenosine Triphosphate; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Screening Assays, Antitumor; Female; Humans; Korea; Male; Middle Aged; Outcome Assessment, Health Care; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Treatment Outcome | 2010 |
A sensitive and specific liquid chromatography/tandem mass spectrometry method for determination of pinaverium bromide in human plasma: application to a pharmacokinetic study in healthy volunteers.
Topics: Administration, Oral; Chromatography, Liquid; Cross-Over Studies; Drug Stability; Humans; Least-Squares Analysis; Male; Morpholines; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Young Adult | 2011 |
Integration of diffusion-weighted MRI data and a simple mathematical model to predict breast tumor cellularity during neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Survival; Chemotherapy, Adjuvant; Cisplatin; Computer Simulation; Diffusion Magnetic Resonance Imaging; Drug Therapy, Computer-Assisted; Everolimus; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Middle Aged; Models, Biological; Paclitaxel; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Sirolimus; Systems Integration; Treatment Outcome | 2011 |
Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions.
Topics: Aged; Biomarkers; Blood Vessel Prosthesis Implantation; Creatine Kinase; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Postoperative Complications; Practice Guidelines as Topic; Prognosis; Prospective Studies; Reference Standards; Sensitivity and Specificity; Sirolimus; Survival Analysis; Troponin; United States; United States Food and Drug Administration; World Health Organization | 2012 |
Is magnetic resonance imaging useful in early evaluation of women on neoadjuvant chemotherapy for locally advanced cervical cancer?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; False Negative Reactions; Female; Humans; Ifosfamide; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Sensitivity and Specificity; Taxoids; Uterine Cervical Neoplasms | 2012 |
Blood oxygenation level-dependent (BOLD) contrast magnetic resonance imaging (MRI) for prediction of breast cancer chemotherapy response: a pilot study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Contrast Media; Cyclophosphamide; Doxorubicin; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Oxygen; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
Imaging the early response to chemotherapy in advanced lung cancer with diffusion-weighted magnetic resonance imaging compared to fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Diffusion Magnetic Resonance Imaging; Early Detection of Cancer; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors.
Topics: Adolescent; Adult; Aged; Biological Availability; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Neoplasms; Paclitaxel; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Taxoids; Treatment Outcome | 2002 |
Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Confidence Intervals; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Neoplasms; Paclitaxel; Probability; Risk Assessment; Sensitivity and Specificity; Survival Rate; Taxoids; Treatment Outcome | 2002 |
Long-term survival in a phase III, randomised study of topotecan versus paclitaxel in advanced epithelial ovarian carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Disease Progression; Drug Administration Schedule; Female; Humans; Incidence; Infusions, Intravenous; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Quality of Life; Sensitivity and Specificity; Survival Analysis; Topotecan | 2004 |
O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma.
Topics: Antineoplastic Agents; Brain Neoplasms; Convection; Drug Delivery Systems; Female; Glioblastoma; Humans; Infusions, Intralesional; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tyrosine | 2005 |
Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2005 |
Are drug-eluting stents cost-effective when compared with bare-metal stents in a real-world setting?
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Cost-Benefit Analysis; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Paclitaxel; Probability; Prosthesis Design; Risk Assessment; Sensitivity and Specificity; Sirolimus; Stents; Survival Rate; Treatment Outcome | 2006 |
Economic analysis of the use of drug-eluting stents from the perspective of Belgian health care.
Topics: Angioplasty, Balloon, Coronary; Belgium; Coronary Artery Bypass; Coronary Restenosis; Cost-Benefit Analysis; Drug-Eluting Stents; Follow-Up Studies; Humans; Metals; Paclitaxel; Prosthesis Design; Reoperation; Research Design; Retrospective Studies; Sensitivity and Specificity; Sirolimus; Treatment Outcome | 2007 |
Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin, in resistant solid tumor malignancies.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chromatography, Liquid; Docosahexaenoic Acids; Drug Resistance, Neoplasm; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Paclitaxel; Sensitivity and Specificity; Tandem Mass Spectrometry | 2009 |
The role of radioimmunoscintigraphy and computed tomography scan prior to reassessment laparotomy of patients with ovarian carcinoma. A preliminary report.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma; Cisplatin; Combined Modality Therapy; Female; Humans; Image Processing, Computer-Assisted; Indium Radioisotopes; Laparotomy; Mice; Middle Aged; Neoplasm, Residual; Oligopeptides; Ovarian Neoplasms; Paclitaxel; Pentetic Acid; Predictive Value of Tests; Prospective Studies; Radioimmunodetection; Remission Induction; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1996 |
Pharmacoeconomic profile of paclitaxel as a first-line treatment for patients with advanced ovarian carcinoma. A lifetime cost-effectiveness analysis.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Cost-Benefit Analysis; Cyclophosphamide; Female; Hospitalization; Humans; Life Expectancy; Ovarian Neoplasms; Paclitaxel; Sensitivity and Specificity | 1996 |
Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography.
Topics: Aged; Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Docetaxel; Female; Humans; Neoplasms; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Taxoids | 1997 |
Determination of paclitaxel in human plasma using single solvent extraction prior to isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection.
Topics: Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Humans; Injections, Intravenous; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1998 |
Assay of paclitaxel (Taxol) in plasma and urine by high-performance liquid chromatography.
Topics: Antineoplastic Agents, Phytogenic; Child; Chromatography, High Pressure Liquid; Drug Stability; Humans; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity | 1998 |
Cost-effectivenes of paclitaxel plus cisplatin in advanced non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Canada; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Humans; Lung Neoplasms; Paclitaxel; Retrospective Studies; Sensitivity and Specificity; Survival Analysis | 1999 |
The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy, Needle; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Paclitaxel; Physical Examination; Premedication; Prospective Studies; Ranitidine; Remission Induction; Sensitivity and Specificity; Ultrasonography | 2000 |
166 other study(ies) available for paclitaxel and Sensitivity and Specificity
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Necrosis; Nutritional Requirements; Pancreatic Neoplasms; Phytotherapy; Plant Extracts; Propolis; Sensitivity and Specificity | 2008 |
Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.
Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Coumarins; Drug Resistance, Multiple; Humans; Molecular Structure; Neoplasms; Oxygen; Pyranocoumarins; Pyrans; Sensitivity and Specificity; Structure-Activity Relationship; Substrate Specificity | 2008 |
Synthesis, biological evaluation and radiochemical labeling of a dansylhydrazone derivative as a potential imaging agent for apoptosis.
Topics: Apoptosis; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Contrast Media; Cytoplasm; Dansyl Compounds; Female; Fluorine Radioisotopes; Humans; Hydrazines; Isotope Labeling; Molecular Structure; Molecular Weight; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stereoisomerism | 2008 |
Development and validation of a liquid chromatography tandem mass spectrometry quantification method for 14 cytotoxic drugs in environmental samples.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Cyclophosphamide; Cytarabine; Deoxycytidine; Doxorubicin; Environmental Pollutants; Gemcitabine; Occupational Exposure; Paclitaxel; Sensitivity and Specificity; Tandem Mass Spectrometry | 2020 |
Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Etoposide; Female; Humans; Logistic Models; Lung; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Radiation Pneumonitis; Radiotherapy, Intensity-Modulated; Respiratory Function Tests; Retrospective Studies; Risk; ROC Curve; Sensitivity and Specificity; Severity of Illness Index | 2020 |
CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal; Carboplatin; CD24 Antigen; Cell Line, Tumor; Cystadenocarcinoma, Serous; Female; Fluorescent Dyes; Humans; Mice; Middle Aged; Molecular Imaging; Neoplasm Grading; Neoplasm Transplantation; Optical Imaging; Ovarian Neoplasms; Paclitaxel; Sensitivity and Specificity | 2020 |
Computed tomography reconstruction for evaluating response in axillary lymph nodes of breast cancer after neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multidetector Computed Tomography; Neoadjuvant Therapy; Neoplasm, Residual; Paclitaxel; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2021 |
Subharmonic-Aided Pressure Estimation for Monitoring Interstitial Fluid Pressure in Tumors: Calibration and Treatment with Paclitaxel in Breast Cancer Xenografts.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Calibration; Cell Line, Tumor; Drug Monitoring; Extracellular Fluid; Female; Humans; Image Interpretation, Computer-Assisted; Manometry; Paclitaxel; Pressure; Rats; Rats, Nude; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Ultrasonography | 2017 |
Simultaneous LC-MS/MS bioanalysis of etoposide and paclitaxel in mouse tissues and plasma after oral administration of self-microemulsifying drug-delivery systems.
Topics: Administration, Oral; Animals; Chromatography, Liquid; Drug Delivery Systems; Drug Stability; Emulsions; Etoposide; Linear Models; Male; Mice; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tissue Distribution | 2018 |
Analytical and clinical validation of a dried blood spot assay for the determination of paclitaxel using high-performance liquid chromatography-tandem mass spectrometry.
Topics: Chromatography, High Pressure Liquid; Dried Blood Spot Testing; Drug Monitoring; Female; Humans; Male; Paclitaxel; Sensitivity and Specificity; Tandem Mass Spectrometry | 2018 |
Tumor-stromal cross-talk modulating the therapeutic response in pancreatic cancer.
Topics: Cancer-Associated Fibroblasts; Carcinoma, Pancreatic Ductal; Cell Survival; Coculture Techniques; Deoxycytidine; Female; Gemcitabine; Humans; Male; Paclitaxel; Pancreatic Neoplasms; Risk Factors; Sensitivity and Specificity; Stromal Cells; Tumor Cells, Cultured | 2018 |
Response of head and neck epithelial cells to a DNA damage-differentiation checkpoint involving polyploidization.
Topics: Biopsy, Needle; Cell Cycle Checkpoints; Cell Proliferation; Cells, Cultured; Cyclin E; DNA Damage; Doxorubicin; Epithelial Cells; Female; Humans; Keratinocytes; Male; Nocodazole; Oncogene Proteins; Paclitaxel; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2018 |
Effect of Xiao-Ai-Ping injection on paclitaxel pharmacokinetics in rats by LC-MS/MS method.
Topics: Animals; Antineoplastic Agents, Phytogenic; Calibration; Chromatography, Liquid; Drugs, Chinese Herbal; Female; Herb-Drug Interactions; Linear Models; Paclitaxel; Quality Control; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2019 |
Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy.
Topics: Algorithms; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Artifacts; Bevacizumab; Body Water; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; MCF-7 Cells; Mice; Mice, SCID; Neoplasms, Experimental; Neovascularization, Pathologic; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2014 |
Pharmacokinetic and tissue distribution of paclitaxel in rabbits assayed by LC-UV after intravenous administration of its novel liposomal formulation.
Topics: Animals; Chromatography, High Pressure Liquid; Drug Stability; Linear Models; Liposomes; Paclitaxel; Rabbits; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2014 |
Determination of paclitaxel in hyaluronic acid polymeric micelles in rat blood by protein precipitation-micelle breaking method: application to a pharmacokinetic study.
Topics: Animals; Chemical Precipitation; Chromatography, High Pressure Liquid; Drug Carriers; Drug Stability; Female; Hyaluronic Acid; Linear Models; Micelles; Paclitaxel; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2013 |
A rapid analytical method for the quantification of paclitaxel in rat plasma and brain tissue by high-performance liquid chromatography and tandem mass spectrometry.
Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Drug Stability; Linear Models; Paclitaxel; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2013 |
[A prospective study of adenosine triphosphate-tumor chemosensitivity assay directed chemotherapy in patients with recurrent ovarian cancer].
Topics: Adenocarcinoma; Adenosine Triphosphate; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Survival Rate | 2013 |
Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Coronary Stenosis; Cross-Sectional Studies; Drug-Eluting Stents; Equipment Failure Analysis; Everolimus; Female; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Design; Prosthesis Failure; Sensitivity and Specificity; Sirolimus; Time Factors; Tomography, Optical Coherence | 2014 |
Rapid and sensitive liquid chromatography coupled with electrospray ionization tandem mass spectrometry method for the analysis of paclitaxel, docetaxel, vinblastine, and vinorelbine in human plasma.
Topics: Antineoplastic Agents; Calibration; Carcinoma, Non-Small-Cell Lung; Chromatography, High Pressure Liquid; Docetaxel; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Lung Neoplasms; Male; Paclitaxel; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Taxoids; Vinblastine; Vinorelbine | 2014 |
Evaluation of progression prior to surgery after neoadjuvant chemoradiotherapy with computed tomography in esophageal cancer patients.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Disease Progression; Esophageal Neoplasms; Esophagectomy; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Preoperative Care; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2014 |
Correlation of (18)F-FDG avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer.
Topics: Aged; Aged, 80 and over; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Conformal; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
Higher predictive value of tumour and node [18F]-FDG PET metabolic volume and TLG in advanced lung cancer under chemotherapy.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Tumor Burden | 2014 |
Matted nodes as a predictor of distant metastasis in advanced-stage III/IV oropharyngeal squamous cell carcinoma.
Topics: Biomarkers; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Follow-Up Studies; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Metastasis; Oropharyngeal Neoplasms; Paclitaxel; Predictive Value of Tests; Radiotherapy, Intensity-Modulated; Sensitivity and Specificity | 2016 |
ATP-based chemotherapy response assay in primary or recurrent ovarian and peritoneal cancer.
Topics: Adenocarcinoma, Clear Cell; Adenosine Triphosphate; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Ovarian Epithelial; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Ifosfamide; Irinotecan; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Taxoids | 2014 |
Roles of the Bcl-2/Bax ratio, caspase-8 and 9 in resistance of breast cancer cells to paclitaxel.
Topics: Analysis of Variance; Antineoplastic Agents, Phytogenic; bcl-2-Associated X Protein; Biomarkers, Tumor; Breast Neoplasms; Caspase 8; Caspase 9; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Sensitivity and Specificity | 2014 |
A novel biosensor for quantitative monitoring of on-target activity of paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; Biosensing Techniques; Drug Monitoring; Equipment Design; Equipment Failure Analysis; Fluorescence Resonance Energy Transfer; Nanocapsules; Nanoconjugates; Paclitaxel; Particle Size; Reproducibility of Results; Sensitivity and Specificity; Silicon Dioxide; Tubulin | 2015 |
Vascular response after Zilver PTX stent implantation for superficial femoral artery lesions: serial optical coherence tomography findings at 6 and 12 months.
Topics: Aged; Aged, 80 and over; Alloys; Cardiovascular Agents; Drug-Eluting Stents; Female; Femoral Artery; Follow-Up Studies; Humans; Male; Neointima; Paclitaxel; Peripheral Arterial Disease; Predictive Value of Tests; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, Optical Coherence; Treatment Outcome | 2015 |
Highly Selective Electrochemical Determination of Taxol Based on ds-DNA-Modified Pencil Electrode.
Topics: DNA; Electrochemical Techniques; Electrodes; Paclitaxel; Sensitivity and Specificity | 2015 |
Predicting paclitaxel-induced neutropenia using the DMET platform.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Cohort Studies; Female; Humans; Male; Membrane Transport Proteins; Middle Aged; Neutropenia; Oligonucleotide Array Sequence Analysis; Paclitaxel; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Young Adult | 2015 |
Quantification of Paclitaxel and Polyaspartate Paclitaxel Conjugate in Beagle Plasma: Application to a Pharmacokinetic Study.
Topics: Animals; Chromatography, Liquid; Dogs; Female; Linear Models; Male; Paclitaxel; Peptides; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2017 |
Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging.
Topics: Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Female; Heterografts; Humans; Image Processing, Computer-Assisted; Male; Mice; Neoplasm Transplantation; Neoplasms; Paclitaxel; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2016 |
Simultaneous quantification of reparixin and paclitaxel in plasma and urine using ultra performance liquid chromatography-tandem mass spectroscopy (UHPLC-MS/MS): Application to a preclinical pharmacokinetic study in rats.
Topics: Animals; Chromatography, High Pressure Liquid; Linear Models; Male; Paclitaxel; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Sulfonamides; Tandem Mass Spectrometry | 2017 |
FDG positron emission tomography imaging of drug-induced pneumonitis.
Topics: Aged; Anxiety Disorders; Brain Neoplasms; Breast Neoplasms; Dibenzothiazepines; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pneumonia; Positron-Emission Tomography; Quetiapine Fumarate; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-125 Antigen; Carboplatin; Carcinoma; Chemotherapy, Adjuvant; Female; Humans; Incidence; Korea; Male; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Treatment Outcome | 2008 |
Ultra-sensitive quantification of paclitaxel using selective solid-phase extraction in conjunction with reversed-phase capillary liquid chromatography/tandem mass spectrometry.
Topics: Antineoplastic Agents, Phytogenic; Calibration; Cell Line, Tumor; Chromatography, Liquid; Female; Humans; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry | 2008 |
Determination of a hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel in rat plasma by LC-MS/MS.
Topics: Animals; Chromatography, High Pressure Liquid; Docetaxel; Female; Paclitaxel; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Taxoids; Time Factors | 2009 |
Determination of a novel paclitaxel derivative (NPD-103) in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry.
Topics: Carbon Isotopes; Chromatography, Liquid; Humans; Methyl Ethers; Paclitaxel; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2009 |
Determination of paclitaxel and other six taxoids in Taxus species by high-performance liquid chromatography-tandem mass spectrometry.
Topics: Antineoplastic Agents, Phytogenic; Calibration; Chromatography, High Pressure Liquid; Feasibility Studies; Molecular Structure; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Species Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Taxoids; Taxus | 2009 |
Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).
Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Critical Pathways; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Probability; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric; Stents; Survival Rate; Treatment Outcome | 2008 |
Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Topics: Antineoplastic Agents; Apoptosis; Cations; Cell Line, Tumor; Cell Survival; Down-Regulation; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HeLa Cells; Humans; Molecular Structure; Nanoparticles; Paclitaxel; Particle Size; Polymers; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; RNA, Small Interfering; Sensitivity and Specificity | 2009 |
Highly selective and sensitive assay for paclitaxel accumulation by tumor cells based on selective solid phase extraction and micro-flow liquid chromatography coupled to mass spectrometry.
Topics: Antineoplastic Agents, Phytogenic; Chromatography, Liquid; Female; Humans; Mass Spectrometry; Ovarian Neoplasms; Paclitaxel; Sensitivity and Specificity; Tumor Cells, Cultured | 2008 |
Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer.
Topics: Acid Ceramidase; Animals; Cell Line, Tumor; Ceramides; Enzyme Activation; Enzyme Inhibitors; Humans; Male; Mice; Mice, Nude; Myristates; Paclitaxel; Phosphotransferases (Alcohol Group Acceptor); Propanolamines; Prostatic Neoplasms; Radiation-Sensitizing Agents; RNA, Small Interfering; Sensitivity and Specificity; Sphingosine; Up-Regulation; Xenograft Model Antitumor Assays | 2009 |
Stereochemical differentiation of C-7 hydroxyltaxane isomers by electrospray ionization mass spectrometry.
Topics: Chromatography, Liquid; Models, Molecular; Molecular Structure; Paclitaxel; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Taxoids | 2009 |
Thermosensitive poly(organophosphazene)-paclitaxel conjugate gels for antitumor applications.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Female; Gels; Humans; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Organophosphorus Compounds; Paclitaxel; Phase Transition; Polymers; Positron-Emission Tomography; Sensitivity and Specificity; Temperature; Water; Xenograft Model Antitumor Assays | 2009 |
Prospective comparison of clinical and genomic multivariate predictors of response to neoadjuvant chemotherapy in breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Breast Neoplasms; Carcinoma; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Neoadjuvant Therapy; Oligonucleotide Array Sequence Analysis; Paclitaxel; Prognosis; Sensitivity and Specificity | 2010 |
Simultaneous determination of anthracyclines and taxanes in human serum using online sample extraction coupled to high performance liquid chromatography with UV detection.
Topics: Anthracyclines; Antineoplastic Agents; Blood Proteins; Calibration; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Daunorubicin; Docetaxel; Doxorubicin; Epirubicin; Humans; Paclitaxel; Sensitivity and Specificity; Taxoids | 2010 |
Microplate spectrophotometry for high-throughput screening of cytotoxic molecules.
Topics: Animals; B-Lymphocytes; Cell Adhesion; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Colchicine; Culture Media; Cytotoxins; Epithelial Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Idarubicin; Kinetics; Leukemia, Biphenotypic, Acute; Paclitaxel; Sensitivity and Specificity; Spectrophotometry; T-Lymphocytes; Time Factors | 2010 |
Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vandetanib in a mouse model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Disease Models, Animal; ErbB Receptors; Flow Cytometry; Head and Neck Neoplasms; Humans; Male; Mice; Mice, Nude; Molecular Targeted Therapy; Paclitaxel; Piperidines; Protein-Tyrosine Kinases; Quinazolines; Random Allocation; Sensitivity and Specificity; Survival Rate; Tumor Cells, Cultured; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2011 |
Chemotherapy induces macrophage chemoattractant protein-1 production in ovarian cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Line, Tumor; Chemokine CCL2; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunohistochemistry; Macrophages; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Signal Transduction; Up-Regulation | 2010 |
Development and validation of a nylon6 nanofibers mat-based SPE coupled with HPLC method for the determination of docetaxel in rabbit plasma and its application to the relative bioavailability study.
Topics: Animals; Area Under Curve; Biological Availability; Caprolactam; Chromatography, High Pressure Liquid; Docetaxel; Drug Stability; Female; Least-Squares Analysis; Male; Nanofibers; Paclitaxel; Polymers; Rabbits; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Taxoids | 2010 |
Competitive mass spectrometry binding assay for characterization of three binding sites of tubulin.
Topics: Animals; Binding Sites; Binding, Competitive; Cattle; Chromatography, Liquid; Colchicine; Docetaxel; Guanosine Triphosphate; Linear Models; Paclitaxel; Podophyllotoxin; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Taxoids; Thiazoles; Tubulin; Tubulin Modulators; Vinblastine; Vincristine | 2010 |
Clinical pharmacokinetics of paclitaxel liposome with a new route of administration in human based on the analysis with ultra performance liquid chromatography.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Chromatography, High Pressure Liquid; Drug Administration Routes; Humans; Linear Models; Liposomes; Middle Aged; Paclitaxel; Pleural Cavity; Pleural Effusion, Malignant; Sensitivity and Specificity | 2010 |
Inhibitory effects of miRNA-200c on chemotherapy-resistance and cell proliferation of gastric cancer SGC7901/DDP cells.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; bcl-2-Associated X Protein; Cadherins; Cell Line, Tumor; Cell Proliferation; Cisplatin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorouracil; Humans; MicroRNAs; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Sensitivity and Specificity; Stomach Neoplasms; Transfection | 2010 |
[Application of ATP-tumor chemosensitivity assay in recurrent epithelial ovarian cancer].
Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Endometrioid; Cystadenocarcinoma, Serous; Deoxycytidine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Luminescent Measurements; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Topotecan | 2010 |
Prediction of pathologic complete response to sequential paclitaxel and 5-fluorouracil/epirubicin/cyclophosphamide therapy using a 70-gene classifier for breast cancers.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Gene Expression Profiling; Humans; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Sensitivity and Specificity | 2011 |
[Predicting clinical chemo-sensitivity of primary ovarian cancer using adenosine triphosphate-tumor chemosensitivity assay combined with detection of drug resistance genes].
Topics: Adenosine Triphosphate; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; CA-125 Antigen; Cisplatin; DNA-Binding Proteins; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Endonucleases; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Real-Time Polymerase Chain Reaction; Regression Analysis; RNA, Messenger; Sensitivity and Specificity | 2011 |
Evaluation of CYP2C8 inhibition in vitro: utility of montelukast as a selective CYP2C8 probe substrate.
Topics: Acetates; Amodiaquine; Aryl Hydrocarbon Hydroxylases; Binding Sites; Carbamates; Cyclopropanes; Cytochrome P-450 CYP2C8; Drug Interactions; Humans; Microsomes, Liver; Paclitaxel; Piperidines; Quinolines; Rosiglitazone; Sensitivity and Specificity; Substrate Specificity; Sulfides; Thiazolidinediones | 2011 |
Quantitation of paclitaxel and its two major metabolites using a liquid chromatography-electrospray ionization tandem mass spectrometry.
Topics: Analysis of Variance; Chemical Hazard Release; Chromatography, Liquid; Drug Stability; Humans; Linear Models; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Taxoids | 2011 |
Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Carboplatin; Contrast Media; Cyclophosphamide; Doxorubicin; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Ki-67 Antigen; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Neoplasms, Hormone-Dependent; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Sensitivity and Specificity; Trastuzumab; Treatment Outcome | 2011 |
A sensitive combined assay for the quantification of paclitaxel, docetaxel and ritonavir in human plasma using liquid chromatography coupled with tandem mass spectrometry.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Docetaxel; Humans; Neoplasms; Paclitaxel; Ritonavir; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Taxoids | 2011 |
A simple and rapid 3D view method for selective and sensitive determination of paclitaxel in micro volume rat plasma by LC-diode array UV and its application to a pharmacokinetic study.
Topics: Acetonitriles; Animals; Chromatography, Reverse-Phase; Linear Models; Liquid-Liquid Extraction; Male; Paclitaxel; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2012 |
Direct and fast determination of paclitaxel, morphine and codeine in urine by micellar electrokinetic chromatography.
Topics: Analgesics, Opioid; Antineoplastic Agents, Phytogenic; Chromatography, Micellar Electrokinetic Capillary; Codeine; Humans; Morphine; Neoplasms; Paclitaxel; Sensitivity and Specificity; Time Factors | 2012 |
Serum levels of TUBB3 correlate with clinical outcome in Chinese patients with advanced gastric cancer receiving first-line paclitaxel plus capecitabine.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Asian People; Biomarkers, Tumor; Capecitabine; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Prognosis; ROC Curve; Sensitivity and Specificity; Stomach Neoplasms; Tubulin; Young Adult | 2012 |
User-defined protein marker assay development for characterization of circulating tumor cells using the CellSearch® system.
Topics: Apoptosis; Biomarkers, Tumor; Cell Count; Cell Line, Tumor; Cell Movement; Flow Cytometry; Green Fluorescent Proteins; Humans; Hyaluronan Receptors; Keratin-18; Neoplasm Metastasis; Neoplasm Proteins; Neoplastic Stem Cells; Paclitaxel; Peptide Fragments; Reagent Kits, Diagnostic; Sensitivity and Specificity; Software; Time Factors | 2012 |
Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays.
Topics: Antineoplastic Agents; Biological Assay; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Collagen; Diffusion Chambers, Culture; Drug Combinations; Electric Impedance; Endpoint Determination; Female; Gentian Violet; Humans; Laminin; Paclitaxel; Proteoglycans; Reproducibility of Results; Rhodamines; Sensitivity and Specificity | 2012 |
A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Disease-Free Survival; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nomograms; Ovarian Neoplasms; Paclitaxel; Platinum; Prognosis; Sensitivity and Specificity; Treatment Outcome | 2013 |
Isolation and genomic characterization of stem cells in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Cell Cycle; Cell Proliferation; Cell Separation; Cisplatin; Flow Cytometry; Gene Expression Regulation, Neoplastic; Genomics; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Neoplastic Stem Cells; Paclitaxel; Radiation Tolerance; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tumor Cells, Cultured | 2013 |
Natural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-up.
Topics: Aged; Angina Pectoris; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Prolapse; Prosthesis Failure; Retrospective Studies; Sensitivity and Specificity; Sirolimus; Thrombosis; Tomography, Optical Coherence | 2013 |
Development and validation of RP-HPLC method: scope of application in the determination of oil solubility of paclitaxel.
Topics: Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Linear Models; Oils; Olive Oil; Paclitaxel; Plant Oils; Reproducibility of Results; Sensitivity and Specificity; Solubility; Triacetin | 2014 |
High-performance liquid chromatographic assay for the determination of the novel C-Seco-taxane derivative (IDN 5390) in mouse plasma.
Topics: Animals; Bridged-Ring Compounds; Chromatography, High Pressure Liquid; Female; Mice; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Taxoids | 2002 |
In vitro comparative evaluation of trastuzumab (Herceptin) combined with paclitaxel (Taxol) or docetaxel (Taxotere) in HER2-expressing human breast cancer cell lines.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Female; Flow Cytometry; Gene Expression Regulation; Genes, erbB-2; Humans; Immunohistochemistry; Paclitaxel; Probability; Sensitivity and Specificity; Statistics, Nonparametric; Taxoids; Trastuzumab; Tumor Cells, Cultured | 2002 |
Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma.
Topics: Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Docetaxel; Humans; Paclitaxel; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Taxoids | 2003 |
Quantification of human Alu sequences by real-time PCR--an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants.
Topics: Alu Elements; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Colonic Neoplasms; DNA, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Mice; Mice, SCID; Neoplasms; Paclitaxel; Pancreatic Neoplasms; Piperazines; Polymerase Chain Reaction; Pyrimidines; Sensitivity and Specificity; Transplantation, Heterologous; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
Microtubule-associated parameters as predictive markers of docetaxel activity in advanced breast cancer patients: results of a pilot study.
Topics: Adult; Aged; Biomarkers, Tumor; Biopsy, Needle; Bone Neoplasms; Breast Neoplasms; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Microtubules; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Pilot Projects; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Soft Tissue Neoplasms; Survival Analysis; tau Proteins; Taxoids; Treatment Outcome; Tubulin | 2002 |
Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assay.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Paclitaxel; Rats; Reproducibility of Results; Sensitivity and Specificity | 2003 |
Interobserver variability in the radiological assessment of response to chemotherapy in glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Dacarbazine; Ependymoma; Female; Glioblastoma; Glioma; Humans; Image Enhancement; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Oligodendroglioma; Paclitaxel; Procarbazine; Sensitivity and Specificity; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2003 |
Drug interactions of paclitaxel metabolism in human liver microsomes.
Topics: Adult; Antineoplastic Agents; Biological Availability; Cells, Cultured; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Microsomes, Liver; Observer Variation; Paclitaxel; Sensitivity and Specificity | 2003 |
A tubulin-based fluorescent polarization assay for paclitaxel.
Topics: Animals; Biological Assay; Cattle; Fluorescence Polarization; Fluorescent Dyes; Humans; Kinetics; Paclitaxel; Reproducibility of Results; Rhodamines; Sensitivity and Specificity; Tubulin | 2003 |
Role of sensory nerve peptides rather than mast cell histamine in paclitaxel hypersensitivity.
Topics: Analysis of Variance; Animals; Biopsy, Needle; Bronchoalveolar Lavage Fluid; Calcitonin Gene-Related Peptide; Disease Models, Animal; Drug Hypersensitivity; Histamine; Immunohistochemistry; Infusions, Intravenous; Male; Mast Cells; Neurokinin A; Neuropeptides; Paclitaxel; Probability; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Sensory Receptor Cells; Substance P | 2004 |
Effects of intraperitoneal administration of gemcitabine and paclitaxel on hepatic regeneration in rats.
Topics: Animals; Biopsy, Needle; Deoxycytidine; Disease Models, Animal; Gemcitabine; Hepatectomy; Immunohistochemistry; Injections, Intraperitoneal; Liver; Liver Function Tests; Liver Regeneration; Male; Paclitaxel; Rats; Rats, Inbred Strains; Sensitivity and Specificity | 2003 |
Determination of paclitaxel in mouse plasma and brain tissue by liquid chromatography-mass spectrometry.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Chemistry; Mice; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2003 |
Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Needle; Breast Neoplasms; Case-Control Studies; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Postoperative Care; Preoperative Care; Proteomics; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2004 |
A scalable high-content cytotoxicity assay insensitive to changes in mitochondrial metabolic activity.
Topics: Antineoplastic Agents; Bleomycin; Cell Death; Cell Line, Tumor; Cell Nucleus; Cell Shape; Formazans; Humans; Mitochondria; Paclitaxel; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Toxicity Tests | 2004 |
Usefulness of collagen gel droplet embedded culture drug sensitivity testing in ovarian cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Culture Techniques; Cell Line, Tumor; Chemotherapy, Adjuvant; Cisplatin; Clinical Laboratory Techniques; Collagen; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Gels; Humans; Irinotecan; Middle Aged; Ovarian Neoplasms; Paclitaxel; Pharmaceutical Preparations; Recurrence; Remission Induction; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2004 |
Enhanced method performance due to a shorter chromatographic run-time in a liquid chromatography-tandem mass spectrometry assay for paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; Atmospheric Pressure; Chromatography, High Pressure Liquid; Docetaxel; Humans; Mass Spectrometry; Paclitaxel; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Taxoids | 2004 |
The effect of recombinant GM-CSF on IL-6 and TNF-alpha levels in epithelial ovarian cancer patients who received paclitaxel and cisplatinum: preliminary results.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-6; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Probability; Prognosis; Prospective Studies; Recombinant Proteins; Sensitivity and Specificity; Statistics, Nonparametric; Treatment Outcome; Tumor Necrosis Factor-alpha | 2004 |
Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2004 |
Effects of paclitaxel and docetaxel on EGFR-expressing human carcinoma cells under normoxic versus hypoxic conditions in vitro.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Survival; Docetaxel; Drug Resistance, Neoplasm; ErbB Receptors; Female; Humans; Hypoxia; Male; Neoplasms; Paclitaxel; Probability; Reference Values; Sensitivity and Specificity; Taxoids; Tumor Cells, Cultured | 2004 |
Optimization of the extraction of paclitaxel from Taxus baccata L. by the use of microwave energy.
Topics: Chromatography, High Pressure Liquid; Mass Spectrometry; Methanol; Microwaves; Molecular Conformation; Paclitaxel; Plant Leaves; Reproducibility of Results; Sensitivity and Specificity; Taxus; Water | 2004 |
A simple and sensitive assay for the quantitative analysis of paclitaxel in human and mouse plasma and brain tumor tissue using coupled liquid chromatography and tandem mass spectrometry.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Chromatography, Liquid; Drug Stability; Humans; Mice; Paclitaxel; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2004 |
Paclitaxel quantification in mouse plasma and tissues containing liposome-entrapped paclitaxel by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetics study.
Topics: Animals; Chromatography, Liquid; Freezing; Indicator Dilution Techniques; Liposomes; Male; Mass Spectrometry; Mice; Molecular Structure; Paclitaxel; Reference Standards; Sensitivity and Specificity; Temperature | 2005 |
Intrinsic chemotherapy resistance to the tubulin-binding antimitotic agents in renal cell carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Carcinoma, Renal Cell; Cell Line; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Humans; Immunohistochemistry; Inhibitory Concentration 50; Kidney; Kidney Neoplasms; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Paclitaxel; Phenotype; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Time Factors; Tubulin; Up-Regulation; Vinblastine; Vincristine | 2005 |
Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.
Topics: Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cluster Analysis; Computational Biology; Databases as Topic; DNA, Complementary; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; Mitomycin; Oligonucleotide Array Sequence Analysis; Paclitaxel; Phylogeny; Sensitivity and Specificity; Tissue Distribution; Transfection; Vinblastine; Vinorelbine | 2005 |
Genetically engineered elastin-protein A fusion as a universal platform for homogeneous, phase-separation immunoassay.
Topics: Elastin; Immunoassay; Paclitaxel; Protein Engineering; Recombinant Fusion Proteins; Sensitivity and Specificity; Staphylococcal Protein A; Temperature | 2005 |
A molecular model to explain paclitaxel and docetaxel sensitivity changes through adduct formation with primary amines in electrospray ionization mass spectrometry.
Topics: Amines; Chromatography, Liquid; Docetaxel; Models, Chemical; Models, Molecular; Molecular Structure; Paclitaxel; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Taxoids | 2005 |
Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Chemotherapy, Adjuvant; Cohort Studies; Confidence Intervals; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hysterectomy; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Nucleosomes; Paclitaxel; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 2005 |
[Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
Topics: Adenosine Triphosphate; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cyclophosphamide; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Luminescent Measurements; Middle Aged; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Sensitivity and Specificity | 2005 |
Development and validation of a liquid chromatography-tandem mass spectrometry assay for the quantification of docetaxel and paclitaxel in human plasma and oral fluid.
Topics: Antineoplastic Agents; Chromatography, Liquid; Docetaxel; Drug Stability; Humans; Molecular Structure; Paclitaxel; Reproducibility of Results; Saliva; Sensitivity and Specificity; Tandem Mass Spectrometry; Taxoids | 2005 |
A simple and sensitive assay for the quantitative analysis of paclitaxel and metabolites in human plasma using liquid chromatography/tandem mass spectrometry.
Topics: Antineoplastic Agents, Phytogenic; Calibration; Chromatography, Liquid; Humans; Paclitaxel; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2006 |
Sensitive HPLC method for quantitation of paclitaxel (Genexol in biological samples with application to preclinical pharmacokinetics and biodistribution.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Female; Mice; Mice, Inbred C57BL; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tissue Distribution | 2005 |
[Application of adenosine triphosphate tumor chemosensitive assay system to individual chemotherapy for hepatocellular carcinoma].
Topics: Adenosine Triphosphate; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Hepatocellular; Deoxycytidine; Disease-Free Survival; Drug Screening Assays, Antitumor; Female; Gemcitabine; Humans; Irinotecan; Liver Neoplasms; Male; Middle Aged; Paclitaxel; Postoperative Period; Remission Induction; Sensitivity and Specificity; Survival Rate | 2005 |
The effect of alkylamine additives on the sensitivity of detection for paclitaxel and docetaxel and analysis in plasma of paclitaxel by liquid chromatography-tandem mass spectrometry.
Topics: Amines; Chromatography, Liquid; Docetaxel; Mass Spectrometry; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Taxoids | 2006 |
The impact of paclitaxel or cisplatin-based chemotherapy on sympathetic skin response: a prospective study.
Topics: Adult; Case-Control Studies; Cisplatin; Electric Stimulation; Electromyography; Electrophysiology; Female; Galvanic Skin Response; Humans; Male; Middle Aged; Neoplasms; Paclitaxel; Prospective Studies; Sensitivity and Specificity; Skin; Sympathetic Nervous System | 2005 |
Role of the antiangiogenetic drug paclitaxel on healing of intestinal anastomosis: an experimental study.
Topics: Analysis of Variance; Anastomosis, Surgical; Animals; Antineoplastic Agents, Phytogenic; Colectomy; Colon; Disease Models, Animal; Injections, Intraperitoneal; Intraoperative Care; Paclitaxel; Probability; Random Allocation; Rats; Rats, Wistar; Sensitivity and Specificity; Statistics, Nonparametric; Tensile Strength; Wound Healing | 2005 |
High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Docetaxel; Humans; Paclitaxel; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Taxoids | 2006 |
Herceptin sensitizes ErbB2-overexpressing cells to apoptosis by reducing antiapoptotic Mcl-1 expression.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Apoptosis; Cell Line, Tumor; Etoposide; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Oligoribonucleotides, Antisense; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Sensitivity and Specificity; Trastuzumab; Tumor Cells, Cultured | 2006 |
Simultaneous determination of paclitaxel and a new P-glycoprotein inhibitor HM-30181 in rat plasma by liquid chromatography with tandem mass spectrometry.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzopyrans; Chromatography, Liquid; Isoquinolines; Male; Molecular Structure; Paclitaxel; Rats; Rats, Sprague-Dawley; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tetrazoles | 2006 |
Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiotherapy; Sensitivity and Specificity; Treatment Outcome | 2006 |
Determination of paclitaxel in human plasma following the administration of Genaxol or Genetaxyl by liquid chromatography/tandem mass spectrometry.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Female; Glycerol; Humans; Injections, Intravenous; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2006 |
Rapid separation of four main taxoids in Taxus species by a combined LLP-SPE-HPLC (PAD) procedure.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Humans; Molecular Structure; Paclitaxel; Plants, Medicinal; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Taxoids; Taxus | 2006 |
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Microarray Analysis; Middle Aged; Neoplasm Staging; Oligonucleotides; Paclitaxel; Predictive Value of Tests; Reproducibility of Results; ROC Curve; Sensitivity and Specificity | 2006 |
In situ visualization of paclitaxel distribution and release by coherent anti-Stokes Raman scattering microscopy.
Topics: Microscopy; Paclitaxel; Polymers; Scattering, Radiation; Sensitivity and Specificity; Spectrum Analysis, Raman | 2006 |
In vitro chemosensitivity test to predict chemosensitivity for paclitaxel, using human gastric carcinoma tissues.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Cell Culture Techniques; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Male; Middle Aged; Paclitaxel; Predictive Value of Tests; Sensitivity and Specificity; Stomach Neoplasms; Tumor Cells, Cultured | 2006 |
Rotational-echo double-resonance NMR distance measurements for the tubulin-bound Paclitaxel conformation.
Topics: Animals; Binding Sites; Cattle; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Paclitaxel; Protein Conformation; Rotation; Sensitivity and Specificity; Stereoisomerism; Structure-Activity Relationship; Time Factors; Tubulin | 2007 |
Determination of paclitaxel in human and rat blood samples after administration of low dose paclitaxel by HPLC-UV detection.
Topics: Aged; Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Calibration; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Hydroxybenzoates; Infusions, Intravenous; Middle Aged; Paclitaxel; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2007 |
Data acquisition for the histoculture drug response assay in lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Fluorouracil; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Probability; Retrospective Studies; Sensitivity and Specificity; Tumor Cells, Cultured | 2007 |
Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel.
Topics: Apoptosis; Blotting, Western; Carcinoma, Renal Cell; Caspases; Deoxycytidine; Drug Synergism; Flow Cytometry; Fluorouracil; History, Ancient; Humans; Kidney Neoplasms; Paclitaxel; Sensitivity and Specificity; Tumor Cells, Cultured; Vinblastine | 2007 |
Initial Experience with a Novel Low-Dose Micro-CT System.
Topics: Animals; Coated Materials, Biocompatible; Contrast Media; Coronary Angiography; Coronary Restenosis; Equipment Design; Glioma; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Iohexol; Iopamidol; Mice; Mice, Nude; Miniaturization; Muscle, Skeletal; Neoplasm Transplantation; Paclitaxel; Phantoms, Imaging; Radiation Dosage; Rats; Sensitivity and Specificity; Soft Tissue Neoplasms; Stents; Swine; Tomography Scanners, X-Ray Computed | 2007 |
Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carboplatin; Contrast Media; Cyclophosphamide; Doxorubicin; Female; Gadolinium DTPA; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Predictive Value of Tests; Receptor, ErbB-2; Retrospective Studies; Sensitivity and Specificity; Trastuzumab; Treatment Outcome | 2007 |
Dominant negative Rac1 attenuates paclitaxel-induced apoptosis in human melanoma cells through upregulation of heat shock protein 27: a functional proteomic analysis.
Topics: Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Electrophoresis, Gel, Two-Dimensional; Genes, Dominant; Heat-Shock Proteins; Humans; Melanoma; Mitochondria; Paclitaxel; Peptides; Proteomics; rac1 GTP-Binding Protein; Sensitivity and Specificity; Tumor Cells, Cultured; Up-Regulation | 2007 |
[A case of recurrent gastric cancer with peritoneal dissemination--prolonging life and good QOL by chemotherapy with combined use of paclitaxel].
Topics: Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoembryonic Antigen; Combined Modality Therapy; Drug Administration Schedule; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Quality of Life; Sensitivity and Specificity; Stomach Neoplasms | 2007 |
Management of advanced nodal disease following chemoradiation for head and neck squamous cell carcinoma: role of magnetic resonance imaging.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm, Residual; Paclitaxel; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2007 |
B-type natriuretic peptide as a marker of asymptomatic re-stenosis after coronary implantation of a paclitaxel-eluting stent.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Paclitaxel; Predictive Value of Tests; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2007 |
Quantitative image analysis of intra-tumoral bFGF level as a molecular marker of paclitaxel resistance.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factor 2; HT29 Cells; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Inhibitory Concentration 50; Male; Mice; Mice, SCID; Paclitaxel; Pancreatic Neoplasms; Pharyngeal Neoplasms; Prostatic Neoplasms; Sensitivity and Specificity; Statistics as Topic; Tissue Culture Techniques; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2008 |
Improved high-performance liquid chromatographic detection of paclitaxel in patient's plasma using solid-phase extraction, and semi-micro-bore C18 separation and UV detection.
Topics: Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Ultraviolet Rays | 2007 |
Drug for a while, polymer for life: Is it a good solution?
Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Polymers; Prognosis; Radiography; Risk Assessment; Sensitivity and Specificity; Sirolimus; Survival Analysis; Treatment Outcome | 2008 |
Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinoscopy; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Radiography; Sensitivity and Specificity | 2008 |
Predictive value of individualized tumor response testing by ATP-based chemotherapy response assay in ovarian cancer.
Topics: Adenosine Triphosphate; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Sensitivity and Specificity; Single-Blind Method; Treatment Outcome; Tumor Cells, Cultured | 2008 |
Tubercidin stabilizes microtubules against vinblastine-induced depolymerization, a taxol-like effect.
Topics: Animals; Aorta; Cell Line; Cyanobacteria; Microtubules; Muscle, Smooth, Vascular; Paclitaxel; Plant Extracts; Rats; Sensitivity and Specificity; Tubercidin; Vinblastine | 1995 |
High-performance liquid chromatographic procedure for the quantitative determination of paclitaxel (Taxol) in human plasma.
Topics: Chromatography, High Pressure Liquid; Drug Stability; Freezing; Half-Life; Humans; Neoplasms; Paclitaxel; Quality Control; Sensitivity and Specificity | 1993 |
Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Docetaxel; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Irinotecan; Leukemia, Experimental; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Paclitaxel; Sensitivity and Specificity; Taxoids; Vincristine | 1996 |
Determination of paclitaxel in biological fluids by micellar electrokinetic chromatography.
Topics: Acetonitriles; Antineoplastic Agents, Phytogenic; Docetaxel; Electrophoresis, Capillary; Humans; Linear Models; Micelles; Paclitaxel; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Sodium Dodecyl Sulfate; Taxoids | 1996 |
Economic and policy implications of adopting paclitaxel as first-line therapy for advanced ovarian cancer: an Ontario perspective.
Topics: Antineoplastic Agents, Phytogenic; Cost-Benefit Analysis; Female; Humans; Ontario; Ovarian Neoplasms; Paclitaxel; Practice Guidelines as Topic; Sensitivity and Specificity | 1997 |
Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspases; Cell Death; Cell Nucleus; Cysteine Endopeptidases; Female; G2 Phase; HL-60 Cells; Humans; Indoles; Mitosis; Oncogene Protein p21(ras); Oncogene Proteins, Viral; Ovarian Neoplasms; Paclitaxel; Recombinant Proteins; Sensitivity and Specificity; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
Development of a fluorescence polarization immunoassay (FPIA) for the quantitative determination of paclitaxel.
Topics: Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Fluorescence Polarization Immunoassay; Paclitaxel; Sensitivity and Specificity | 1998 |
CD95-mediated apoptosis: no variation in cellular sensitivity during cell cycle progression.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Aphidicolin; Apoptosis; Camptothecin; Cell Cycle; Cell Death; Cisplatin; Culture Media, Serum-Free; Doxorubicin; Enzyme Inhibitors; Fas Ligand Protein; fas Receptor; Gene Expression; HeLa Cells; Humans; Hydroxyurea; Jurkat Cells; Membrane Glycoproteins; Nimustine; Nocodazole; Paclitaxel; Sensitivity and Specificity; Teniposide; Tumor Cells, Cultured; Vincristine | 1998 |
Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Treatment Outcome | 1998 |
Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cost-Benefit Analysis; Cyclophosphamide; Europe; Female; Health Care Costs; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Sensitivity and Specificity | 1998 |
Rapid and sensitive determination of paclitaxel in mouse plasma by high-performance liquid chromatography.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Half-Life; Male; Mice; Mice, Inbred ICR; Paclitaxel; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1999 |
Activity of SCH 66336, a tricyclic farnesyltransferase inhibitor, against human tumor colony-forming units.
Topics: Alkyl and Aryl Transferases; Cell Survival; Cisplatin; Clone Cells; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Farnesyltranstransferase; Humans; Neoplasms; Neoplastic Stem Cells; Paclitaxel; Piperidines; Pyridines; Sensitivity and Specificity; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1999 |
Pre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicity.
Topics: Adenocarcinoma; Antineoplastic Agents; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Division; Cell Survival; Cisplatin; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Inhibitory Concentration 50; Irinotecan; Lung Neoplasms; Paclitaxel; Sensitivity and Specificity; Taxoids; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured | 1999 |
Liquid chromatographic analysis and preliminary pharmacokinetics of methotrexate in cancer patients co-treated with docetaxel.
Topics: Acetone; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemical Precipitation; Chromatography, High Pressure Liquid; Docetaxel; Humans; Hydroxylation; Kinetics; Methanol; Methotrexate; Neoplasms; Paclitaxel; Rats; Rats, Wistar; Sensitivity and Specificity; Taxoids | 1999 |
High-performance liquid chromatographic assay for the determination of the novel taxane derivative IDN5109 in mouse plasma.
Topics: Animals; Bridged-Ring Compounds; Chromatography, High Pressure Liquid; Drug Stability; Female; Freezing; Kinetics; Mice; Paclitaxel; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Taxoids | 1999 |
High sensitivity ELISA determination of taxol in various human biological fluids.
Topics: Antineoplastic Agents, Phytogenic; Binding, Competitive; Calibration; Enzyme-Linked Immunosorbent Assay; Evaluation Studies as Topic; Feasibility Studies; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Neoplasms; Paclitaxel; Reproducibility of Results; Saliva; Sensitivity and Specificity | 1999 |
Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Paclitaxel; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paclitaxel; Prednisolone; Radiopharmaceuticals; Sensitivity and Specificity; Taxoids; Tomography, Emission-Computed; Vincristine | 2000 |
Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Cyclophosphamide; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epirubicin; Female; Humans; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Regression Analysis; Sensitivity and Specificity; Survival Analysis; Tumor Cells, Cultured | 2000 |
Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity.
Topics: 3T3 Cells; Animals; Antibodies, Monoclonal; Antibody Specificity; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Immunoconjugates; Kinetics; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Protein Binding; Receptor, Nerve Growth Factor; Receptor, trkA; Sensitivity and Specificity; Solubility; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
Thymidine incorporation is highly predictive of colony formation and can be used for high-throughput screening.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Chickens; CHO Cells; Colonic Neoplasms; Colony-Forming Units Assay; Cricetinae; Drug Screening Assays, Antitumor; Etoposide; Humans; Hydroxyurea; Kidney Neoplasms; Lung Neoplasms; Paclitaxel; Sensitivity and Specificity; Thymidine; Tritium; Tumor Cells, Cultured | 2001 |
Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid-liquid extraction.
Topics: Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Docetaxel; Humans; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Taxoids | 2001 |
Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents.
Topics: Animals; Antineoplastic Agents; Female; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Male; Mice; Mice, Nude; Microtubules; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Sensitivity and Specificity; Tissue Distribution; Tubulin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
High-performance liquid chromatography/tandem mass spectrometry for the quantitative analysis of a novel taxane derivative (BAY59-8862) in biological samples and characterisation of its metabolic profile in rat bile samples.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bile; Bridged-Ring Compounds; Chromatography, High Pressure Liquid; Liver; Mass Spectrometry; Mice; Mice, Nude; Molecular Conformation; Molecular Structure; Paclitaxel; Rats; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Taxoids | 2001 |
Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
Topics: Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Drug Screening Assays, Antitumor; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; ROC Curve; Sensitivity and Specificity | 2001 |
Continuous-flow fluoro-immunosensor for paclitaxel measurement.
Topics: Antineoplastic Agents, Phytogenic; Biosensing Techniques; Fluorescent Dyes; Fluoroimmunoassay; Humans; Paclitaxel; Rhodamines; Sensitivity and Specificity | 2001 |
Cost-minimisation analysis of three regimens of chemotherapy (docetaxel-cisplatin, paclitaxel-cisplatin, paclitaxel-carboplatin) for advanced non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Docetaxel; Drug Costs; Economics, Pharmaceutical; Humans; Infusions, Intravenous; Lung Neoplasms; Neoplasm Staging; Paclitaxel; Sensitivity and Specificity; Survival Rate; Taxoids | 2002 |
Economic analysis of the TAX 317 trial: docetaxel versus best supportive care as second-line therapy of advanced non-small-cell lung cancer.
Topics: Antineoplastic Agents, Phytogenic; Canada; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Costs and Cost Analysis; Docetaxel; Hospitalization; Humans; Lung Neoplasms; Paclitaxel; Palliative Care; Radiotherapy; Retrospective Studies; Sensitivity and Specificity; Taxoids | 2002 |
On-line solid-phase extraction and determination of paclitaxel in human plasma.
Topics: Antineoplastic Agents, Phytogenic; Humans; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2002 |
Smoothing low-SNR molecular images via anisotropic median-diffusion.
Topics: Anisotropy; Breast Neoplasms; Computer Simulation; Humans; Image Enhancement; Models, Statistical; Paclitaxel; Phantoms, Imaging; Radiography; Reproducibility of Results; Sensitivity and Specificity; Spectrum Analysis, Raman; Stochastic Processes; Tissue Distribution | 2002 |
Determination of the docetaxel vehicle, polysorbate 80, in patient samples by liquid chromatography-tandem mass spectrometry.
Topics: Antineoplastic Agents, Phytogenic; Calibration; Docetaxel; Humans; Neoplasms; Paclitaxel; Pharmaceutical Vehicles; Polysorbates; Reproducibility of Results; Sensitivity and Specificity; Taxoids | 2002 |
Profiling of yew hair roots from various species using ultra-performance liquid chromatography/electrospray ionization mass spectrometry.
Topics: Chromatography, Liquid; Molecular Structure; Plant Roots; Plants, Medicinal; Sensitivity and Specificity; Species Specificity; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Taxus; Time Factors | 2008 |
Development of an LC-ESI-MS/MS method for the determination of histamine: application to the quantitative measurement of histamine degranulation by KU812 cells.
Topics: Anti-Allergic Agents; Cell Degranulation; Cell Line; Chromatography, Liquid; Cromolyn Sodium; Histamine; Histamine Release; Humans; Least-Squares Analysis; Plant Extracts; Pyrazoles; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Microextraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Taxus; Wood | 2009 |
Application of direct PCR in a forensic case of yew poisoning.
Topics: Base Sequence; DNA, Ribosomal; Forensic Toxicology; Gastrointestinal Contents; Humans; Molecular Sequence Data; Plant Leaves; Polymerase Chain Reaction; Sensitivity and Specificity; Taxus | 2012 |
Monitoring of aglycons of yew glycosides (3,5-dimethoxyphenol, myrtenol and 1-octen-3-ol) as first indicator of yew presence.
Topics: Bicyclic Monoterpenes; Gas Chromatography-Mass Spectrometry; Glycosides; Humans; Hydrolysis; Monoterpenes; Octanols; Phloroglucinol; Plant Extracts; Sensitivity and Specificity; Taxus | 2013 |
Flavanol binding of nuclei from tree species.
Topics: Binding Sites; Catechin; Cell Nucleus; Chromosomes, Plant; Coffea; Flavonols; Plant Leaves; Prunus; Sensitivity and Specificity; Sequoia; Species Specificity; Taxus; Trees; Tsuga; Vacuoles | 2004 |